Loading...

Peter Carroll, MD

Address550 16th. Street
San Francisco CA 94158
Phone415-353-7098
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine -Urology

    Collapse Research 
    Collapse Research Activities and Funding
    Effectiveness of Early Stage Prostate Cancer Treatment
    NIH/NCI RC1CA146596Sep 30, 2009 - Aug 31, 2012
    Role: Principal Investigator
    UCSF KURe Career Development Program
    NIH/NIDDK K12DK083021Sep 30, 2008 - Jul 31, 2018
    Role: Co-Principal Investigator
    Male Reproductive Health Research Career Development Program
    NIH/NICHD K12HD053943Sep 30, 2006 - Aug 31, 2012
    Role: Principal Investigator
    Active Surveillance for Early Stage Prostate Cancer: Selection, Monitoring
    NIH/NCI R13CA121759May 5, 2006 - Apr 30, 2007
    Role: Principal Investigator
    Molecular Effects of Nutrition Supplements in Prostate
    NIH/NCI R01CA101042Jun 10, 2003 - May 31, 2009
    Role: Principal Investigator
    UCSF PROSTATE CANCER SPORE
    NIH/NCI P50CA089520Sep 25, 2000 - Jun 30, 2010
    Role: Principal Investigator
    Cancer Center Support Grant
    NIH/NCI P30CA082103Aug 5, 1999 - May 31, 2018
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Clinical Trials
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg M, Feng F, Chang A, Ryan CJ, Small EJ, Carroll P. Impact of Ga-68 PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer. J Nucl Med. 2017 May 18. PMID: 28522741.
      View in: PubMed
    2. Zhao SG, Chang SL, Erho N, Yu M, Lehrer J, Alshalalfa M, Speers C, Cooperberg MR, Kim W, Ryan CJ, Den RB, Freedland SJ, Posadas E, Sandler H, Klein EA, Black P, Seiler R, Tomlins SA, Chinnaiyan AM, Jenkins RB, Davicioni E, Ross AE, Schaeffer EM, Nguyen PL, Carroll P, Karnes RJ, Spratt DE, Feng FY. Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy. JAMA Oncol. 2017 May 11. PMID: 28494073.
      View in: PubMed
    3. Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll P. Active Surveillance in Younger Men With Prostate Cancer. J Clin Oncol. 2017 Mar 27; JCO2016680058. PMID: 28346806.
      View in: PubMed
    4. Chan B, Reeve E, Matthews S, Carroll P, Long JC, Held F, Latt M, Naganathan V, Caplan G, Hilmer SN. Medicine information exchange networks among health care professionals and prescribing in geriatric medicine wards. Br J Clin Pharmacol. 2016 Dec 23. PMID: 28009444.
      View in: PubMed
    5. Leapman MS, Cowan JE, Simko J, Roberge G, Stohr BA, Carroll P, Cooperberg MR. Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes. Eur Urol. 2016 Dec 08. PMID: 27940155.
      View in: PubMed
    6. Emami NC, Leong L, Wan E, Van Blarigan EL, Cooperberg MR, Tenggara I, Carroll P, Chan JM, Witte JS, Simko JP. Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy. Prostate. 2016 Nov 30. PMID: 27900799.
      View in: PubMed
    7. Lin DW, Newcomb LF, Brown MD, Sjoberg DD, Dong Y, Brooks JD, Carroll P, Cooperberg M, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y. Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study. Eur Urol. 2016 Nov 23. PMID: 27889277.
      View in: PubMed
    8. Eminaga O, Wei W, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll P, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, Feng Z, Fazli L, Brooks JD. MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study. PLoS One. 2016; 11(11):e0165236. PMID: 27846218.
      View in: PubMed
    9. McKenney JK, Wei W, Hawley S, Auman H, Newcomb LF, Boyer HD, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Tretiakova MS, Vakar-Lopez F, Carroll P, Cooperberg MR, Gleave ME, Lance RS, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD. Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort. Am J Surg Pathol. 2016 Nov; 40(11):1439-1456. PMID: 27635949.
      View in: PubMed
    10. Macleod LC, Ellis WJ, Newcomb LF, Zheng Y, Brooks JD, Carroll P, Gleave ME, Lance RS, Nelson PS, Thompson IM, Wagner AA, Wei JT, Lin DW. Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study. J Urol. 2016 Nov 01. PMID: 27810448.
      View in: PubMed
    11. Leapman MS, Carroll P. What is the best way not to treat prostate cancer? Urol Oncol. 2017 Feb; 35(2):42-50. PMID: 27746147.
      View in: PubMed
    12. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll P. Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes. PLoS One. 2016; 11(10):e0164558. PMID: 27711167.
      View in: PubMed
    13. Villa S, Kendel F, Venderbos L, Rancati T, Bangma C, Carroll P, Denis L, Klotz L, Korfage IJ, Lane AJ, Magnani T, Mastris K, Rannikko A, Roobol M, Trock B, Van den Bergh R, Van Poppel H, Valdagni R, Bellardita L. Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force. Eur Urol. 2016 Oct 6. PMID: 27720532.
      View in: PubMed
    14. Wei XX, Chan S, Kwek S, Lewis J, Dao V, Zhang L, Cooperberg MR, Ryan CJ, Lin AM, Friedlander TW, Rini B, Kane C, Simko JP, Carroll P, Small EJ, Fong L. Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer. Cancer Immunol Res. 2016 Sep 29. PMID: 27688020.
      View in: PubMed
    15. Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll P. A randomized study of intra-operative autologous retropubic urethral sling on urinary control after robotic-assisted radical prostatectomy. J Urol. 2016 Sep 27. PMID: 27693447.
      View in: PubMed
    16. Hope TA, Truillet CC, Ehman EC, Afshar-Oromieh A, Aggarwal R, Ryan CJ, Carroll P, Small EJ, Evans MJ. Imaging Response to Androgen Receptor Inhibition Using 68Ga-PSMA-11 PET: First Human Experience. J Nucl Med. 2016 Sep 22. PMID: 27660139.
      View in: PubMed
    17. Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll P, et al. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance. Eur Urol. 2016 Aug 29. PMID: 27595378.
      View in: PubMed
    18. Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll P, Kurhanewicz J, Seo Y, et al. (18)F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology. 2016 Aug 11; 160220. PMID: 27513849.
      View in: PubMed
    19. Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll P, et al. Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy. Clin Genitourin Cancer. 2016 Jul 21. PMID: 27522449.
      View in: PubMed
    20. Liss MA, Schenk JM, Faino AV, Newcomb LF, Boyer H, Brooks JD, Carroll P, Dash A, Fabrizio MD, Gleave ME, Nelson PS, Neuhouser ML, Wei JT, Zheng Y, Wright JL, Lin DW, Thompson IM. A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment. Prostate Cancer Prostatic Dis. 2016 Dec; 19(4):390-394. PMID: 27431498.
      View in: PubMed
    21. Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge M, Leapman M, Pinto P, Thompson IM, Carroll P, Eastham J, Gomella L, Klein EA. An Approach Using PSA Levels of 1.5?ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care. Urology. 2016 Oct; 96:116-120. PMID: 27450937.
      View in: PubMed
    22. McKiernan J, Donovan MJ, O'Neill V, Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A, Andriole G, Brown G, Wei JT, Thompson IM, Carroll P. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. JAMA Oncol. 2016 Jul 1; 2(7):882-9. PMID: 27032035.
      View in: PubMed
    23. Leapman MS, Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Walker K, Amling CL, Carroll P, Cooperberg MR. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy. J Urol. 2016 Nov; 196(5):1408-1414. PMID: 27352635.
      View in: PubMed
    24. Brooks JD, Wei W, Pollack JR, West RB, Shin JH, Sunwoo JB, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll P, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, Feng Z, Fazli L. Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort. Prostate. 2016 Nov; 76(15):1409-19. PMID: 27325561.
      View in: PubMed
    25. Lotan TL, Wei W, Ludkovski O, Morais CL, Guedes LB, Jamaspishvili T, Lopez K, Hawley ST, Feng Z, Fazli L, Hurtado-Coll A, McKenney JK, Simko J, Carroll P, Gleave M, Lin DW, Nelson PS, Thompson IM, True LD, Brooks JD, Lance R, Troyer D, Squire JA. Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH. Mod Pathol. 2016 Aug; 29(8):904-14. PMID: 27174589.
      View in: PubMed
    26. Leapman MS, Carroll P. Immediate androgen deprivation: for all or for some? Lancet Oncol. 2016 Jun; 17(6):683-4. PMID: 27155739.
      View in: PubMed
    27. Leapman MS, Ameli N, Cooperberg MR, Chu C, Hussein A, Shinohara K, Carroll P, et al. Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance. Eur Urol. 2016 May 4. PMID: 27157998.
      View in: PubMed
    28. Tretiakova MS, Wei W, Boyer HD, Newcomb LF, Hawley S, Auman H, Vakar-Lopez F, McKenney JK, Fazli L, Simko J, Troyer DA, Hurtado-Coll A, Thompson IM, Carroll P, Ellis WJ, Gleave ME, Nelson PS, Lin DW, True LD, Feng Z, Brooks JD. Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies. Prostate Cancer Prostatic Dis. 2016 Sep; 19(3):264-70. PMID: 27136741.
      View in: PubMed
    29. Carroll P, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Kim S, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Moses KA, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenkle P, Vickers AJ, Wake R, Shead DA, Freedman-Cass DA. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. J Natl Compr Canc Netw. 2016 May; 14(5):509-19. PMID: 27160230.
      View in: PubMed
    30. Eltemamy MM, Leapman MS, Cowan JE, Westphalen A, Shinohara K, Carroll P. Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance. J Urol. 2016 Sep; 196(3):727-33. PMID: 27117443.
      View in: PubMed
    31. Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. Am J Clin Oncol. 2016 Apr; 39(2):167-72. PMID: 24441584.
      View in: PubMed
    32. Akaza H, Hirao Y, Kim CS, Oya M, Ozono S, Ye D, Cooperberg M, Hinotsu S, Lee JY, Zhu G, Namiki M, Horie S, Chung BH, Chen CH, Fai NC, Hakim L, Chiong E, Letran J, Umbas R, Suzuki K, Nishimura K, Ong TA, Lojanapiwat B, Wu TL, Kim WJ, Murphy D, Ogawa O, Carroll P, Naito S, Tsukamoto T. Asia prostate cancer study (A-CaP Study) launch symposium. Prostate Int. 2016 Sep; 4(3):88-96. PMID: 27689065.
      View in: PubMed
    33. Knudsen BS, Kim HL, Erho N, Shin H, Alshalalfa M, Lam LL, Tenggara I, Chadwich K, Van Der Kwast T, Fleshner N, Davicioni E, Carroll P, Cooperberg MR, Chan JM, Simko JP. Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens. J Mol Diagn. 2016 May; 18(3):395-406. PMID: 26945428.
      View in: PubMed
    34. Bruinsma SM, Bangma CH, Carroll P, Leapman MS, Rannikko A, Petrides N, Weerakoon M, Bokhorst LP, Roobol MJ. Active surveillance for prostate cancer: a narrative review of clinical guidelines. Nat Rev Urol. 2016 Mar; 13(3):151-67. PMID: 26813955.
      View in: PubMed
    35. Brand TC, Zhang N, Crager MR, Maddala T, Dee A, Sesterhenn IA, Simko JP, Cooperberg MR, Srivastava S, Rosner IL, Chan JM, Febbo PG, Carroll P, Cullen J, Lawrence HJ. Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score. Urology. 2016 Mar; 89:69-75. PMID: 26723180.
      View in: PubMed
    36. Carroll P, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenke P, Vickers AJ, Wake R, Shead DA, Freedman-Cass D. Prostate Cancer Early Detection, Version 2.2015. J Natl Compr Canc Netw. 2015 Dec; 13(12):1534-61. PMID: 26656522.
      View in: PubMed
    37. Carlsson S, Leapman M, Carroll P, Schröder F, Albertsen PC, Ilic D, Barry M, Frosch DL, Vickers A. Who and when should we screen for prostate cancer? Interviews with key opinion leaders. BMC Med. 2015; 13:288. PMID: 26612204; PMCID: PMC4662021.
    38. Nordström T, Van Blarigan EL, Ngo V, Roy R, Weinberg V, Song X, Simko J, Carroll P, Chan JM, Paris PL. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate. 2016 Mar; 76(4):339-48. PMID: 26585352.
      View in: PubMed
    39. Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll P, Kim W, Ruggero D. Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors. Sci Signal. 2015; 8(403):ra116. PMID: 26577921.
      View in: PubMed
    40. Cooperberg MR, Carroll P. Treatment Trends for Prostate Cancer--Reply. JAMA. 2015 Nov 10; 314(18):1977-8. PMID: 26547474.
      View in: PubMed
    41. Leapman MS, Carroll P. New Genetic Markers for Prostate Cancer. Urol Clin North Am. 2016 Feb; 43(1):7-15. PMID: 26614025.
      View in: PubMed
    42. Sanford T, McCulloch CE, Callcut RA, Carroll P, Breyer BN. Bicycle Trauma Injuries and Hospital Admissions in the United States, 1998-2013. JAMA. 2015 Sep 1; 314(9):947-9. PMID: 26325564.
      View in: PubMed
    43. Newcomb LF, Thompson IM, Boyer HD, Brooks JD, Carroll P, Cooperberg MR, Dash A, Ellis WJ, Fazli L, Feng Z, Gleave ME, Kunju P, Lance RS, McKenney JK, Meng MV, Nicolas MM, Sanda MG, Simko J, So A, Tretiakova MS, Troyer DA, True LD, Vakar-Lopez F, Virgin J, Wagner AA, Wei JT, Zheng Y, Nelson PS, Lin DW. Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort. J Urol. 2016 Feb; 195(2):313-20. PMID: 26327354.
      View in: PubMed
    44. Brooks JD, Wei W, Hawley S, Auman H, Newcomb L, Boyer H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll P, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, McKenney JK. Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients. PLoS One. 2015; 10(7):e0132343. PMID: 26172920; PMCID: PMC4501723.
    45. Cooperberg MR, Carroll P. Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. JAMA. 2015 Jul 7; 314(1):80-2. PMID: 26151271.
      View in: PubMed
    46. Filippou P, Welty CJ, Cowan JE, Perez N, Shinohara K, Carroll P. Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer. Eur Urol. 2015 Sep; 68(3):458-63. PMID: 26138041.
      View in: PubMed
    47. Dall'Era M, Carroll P. What is the Optimal Way to Select Candidates for Active Surveillance of Prostate Cancer? J Urol. 2015 Sep; 194(3):615-6. PMID: 26079332.
      View in: PubMed
    48. Hilmer SN, Seale JP, Carroll P. A comparison of medical and pharmacy students' knowledge and skills of pharmacology and pharmacotherapy. Br J Clin Pharmacol. 2015 Jun; 79(6):1028-9. PMID: 25425109; PMCID: PMC4456135 [Available on 06/01/16].
    49. Hsu CC, Paciorek AT, Cooperberg MR, Roach M, Hsu IC, Carroll P. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter? BJU Int. 2015 Nov; 116(5):713-20. PMID: 25600860.
      View in: PubMed
    50. Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan JM, Simko JP, Carroll P. Patterns of Local Failure following Radiation Therapy for Prostate Cancer. J Urol. 2015 Oct; 194(4):977-82. PMID: 25983194.
      View in: PubMed
    51. Cooperberg MR, Hinotsu S, Namiki M, Carroll P, Akaza H. Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancer. BJU Int. 2016 Jan; 117(1):102-9. PMID: 25238114.
      View in: PubMed
    52. Troyer DA, Jamaspishvili T, Wei W, Feng Z, Good J, Hawley S, Fazli L, McKenney JK, Simko J, Hurtado-Coll A, Carroll P, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Brooks JD, Squire JA. A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer. Prostate. 2015 Aug 1; 75(11):1206-15. PMID: 25939393; PMCID: PMC4475421 [Available on 08/01/16].
    53. Ankerst DP, Xia J, Thompson IM, Hoefler J, Newcomb LF, Brooks JD, Carroll P, Ellis WJ, Gleave ME, Lance RS, Nelson PS, Wagner AA, Wei JT, Etzioni R, Lin DW. Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator. Eur Urol. 2015 Dec; 68(6):1083-8. PMID: 25819722; PMCID: PMC4583313 [Available on 12/01/16].
    54. Garcia-Albeniz X, Chan JM, Paciorek A, Logan RW, Kenfield SA, Cooperberg MR, Carroll P, Hernán MA. Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study. Eur J Cancer. 2015 May; 51(7):817-24. PMID: 25794605; PMCID: PMC4402138 [Available on 05/01/16].
    55. Hampson LA, Cowan JE, Zhao S, Carroll P, Cooperberg MR. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer. Eur Urol. 2015 Sep; 68(3):480-6. PMID: 25656807.
      View in: PubMed
    56. Hussein AA, Punnen S, Zhao S, Cowan JE, Leapman M, Tran TC, Washington SL, Truesdale MD, Carroll P, Cooperberg MR. Current Use of Imaging after Primary Treatment of Prostate Cancer. J Urol. 2015 Jul; 194(1):98-104. PMID: 25640648.
      View in: PubMed
    57. Schreuder LJ, Carroll P, Muwanguzi-Karugaba J, Kokoczka R, Brown AC, Parish T. Mycobacterium tuberculosis H37Rv has a single nucleotide polymorphism in PhoR which affects cell wall hydrophobicity and gene expression. Microbiology. 2015 Apr; 161(Pt 4):765-73. PMID: 25635271.
      View in: PubMed
    58. Hussein AA, Welty CJ, Ameli N, Cowan JE, Leapman M, Porten SP, Shinohara K, Carroll P. Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes. J Urol. 2015 Jul; 194(1):85-90. PMID: 25623742.
      View in: PubMed
    59. Bangma CH, Valdagni R, Carroll P, van Poppel H, Klotz L, Hugosson J. Active surveillance for low-risk prostate cancer: developments to date. Eur Urol. 2015 Apr; 67(4):646-8. PMID: 25435266.
      View in: PubMed
    60. Ten Ham RM, Wilson LS, Broering JM, Cooperberg MR, Carroll P. Sustainable Measurement of Response Shift in Prostate Cancer Patients: Adjusting Health Related Quality of Life with the Then-Test. Value Health. 2014 Nov; 17(7):A651. PMID: 27202352.
      View in: PubMed
    61. Xia J, Trock BJ, Gulati R, Mallinger L, Cooperberg MR, Carroll P, Carter HB, Etzioni R. Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristics. Clin Cancer Res. 2014 Oct 15; 20(20):5302-10. PMID: 25320374; PMCID: PMC4203422.
    62. Gerstenberger JP, Bauer SR, Van Blarigan EL, Sosa E, Song X, Witte JS, Carroll P, Chan JM. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2015 Jan; 75(1):60-9. PMID: 25284284; PMCID: PMC4257852 [Available on 01/01/16].
    63. Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll P. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol. 2015 Mar; 193(3):807-11. PMID: 25261803.
      View in: PubMed
    64. Fong L, Carroll P, Weinberg V, Chan S, Lewis J, Corman J, Amling CL, Stephenson RA, Simko J, Sheikh NA, Sims RB, Frohlich MW, Small EJ. Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer. J Natl Cancer Inst. 2014 Nov; 106(11). PMID: 25255802; PMCID: PMC4241888.
    65. Punnen S, Cowan JE, Chan JM, Carroll P, Cooperberg MR. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol. 2015 Oct; 68(4):600-8. PMID: 25242555.
      View in: PubMed
    66. Carroll P, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shanefelt TM, Vickers AJ, Wake R, Shead DA, Ho M. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2014 Sep; 12(9):1211-9; quiz 1219. PMID: 25190691.
      View in: PubMed
    67. Klein EA, Cooperberg MR, Carroll P. Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur urol 2014;66:550-60. Eur Urol. 2014 Dec; 66(6):e117-8. PMID: 25150174.
      View in: PubMed
    68. Akaza H, Kim CS, Carroll P, Choi IY, Chung BH, Cooperberg MR, Hirao Y, Hinotsu S, Horie S, Lee JY, Namiki M, Ng CF, Onozawa M, Ozono S, Ueno S, Umbas R, Ye D, Zhu G. Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management. Prostate Int. 2014; 2(2):50-69. PMID: 26153555; PMCID: PMC4099396.
    69. Wang SY, Shiboski S, Belair CD, Cooperberg MR, Simko JP, Stoppler H, Cowan J, Carroll P, Blelloch R. miR-19, miR-345, miR-519c-5p serum levels predict adverse pathology in prostate cancer patients eligible for active surveillance. PLoS One. 2014; 9(6):e98597. PMID: 24893170; PMCID: PMC4043973.
    70. Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll P. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol. 2014 Sep; 66(3):550-60. PMID: 24836057.
      View in: PubMed
    71. Porten SP, Smith A, Odisho AY, Litwin MS, Saigal CS, Carroll P, Cooperberg MR. Updated trends in imaging use in men diagnosed with prostate cancer. Prostate Cancer Prostatic Dis. 2014 Sep; 17(3):246-51. PMID: 24819235; PMCID: PMC4266691.
    72. Carroll P, Vickers AJ. Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences? J Natl Compr Canc Netw. 2014 May; 12(5 Suppl):768-71. PMID: 24853213.
      View in: PubMed
    73. Greene KL, Punnen S, Carroll P. Evolution and immediate future of US screening guidelines. Urol Clin North Am. 2014 May; 41(2):229-35. PMID: 24725485.
      View in: PubMed
    74. Welty CJ, Cooperberg MR, Carroll P. Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer. Curr Opin Urol. 2014 May; 24(3):288-92. PMID: 24614347.
      View in: PubMed
    75. Jalloh M, Myers F, Cowan JE, Carroll P, Cooperberg MR. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics. Eur Urol. 2015 Mar; 67(3):451-7. PMID: 24746973.
      View in: PubMed
    76. Jarow JP, Thompson IM, Kluetz PG, Baxley J, Sridhara R, Scardino P, Carroll P, Albertsen P, Carter HB, Brawley O, Sartor O, Sandler H, Kiefert JJ, Morton RA. Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop. Urology. 2014 May; 83(5):975-8. PMID: 24661332.
      View in: PubMed
    77. Morgan TM, Meng MV, Cooperberg MR, Cowan JE, Weinberg V, Carroll P, Lin DW. A risk-adjusted definition of biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis. 2014 Jun; 17(2):174-9. PMID: 24614692.
      View in: PubMed
    78. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll P. Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes. PLoS One. 2014; 9(3):e89754. PMID: 24594774; PMCID: PMC3940667.
    79. Bennett A, Gnjidic D, Gillett M, Carroll P, Matthews S, Johnell K, Fastbom J, Hilmer S. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study. Drugs Aging. 2014 Mar; 31(3):225-32. PMID: 24452921.
      View in: PubMed
    80. Vickers AJ, Thompson IM, Klein E, Carroll P, Scardino PT. A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. Urology. 2014 Mar; 83(3):592-6. PMID: 24581521.
      View in: PubMed
    81. Welty CJ, Carroll P. The ongoing need for improved risk stratification and monitoring for those on active surveillance for early stage prostate cancer. Eur Urol. 2014 Jun; 65(6):1032-3. PMID: 24636678.
      View in: PubMed
    82. Brajtbord JS, Punnen S, Cowan JE, Welty CJ, Carroll P. Age and baseline quality of life at radical prostatectomy--who has the most to lose? J Urol. 2014 Aug; 192(2):396-401. PMID: 24582539.
      View in: PubMed
    83. Wang SY, Cowan JE, Cary KC, Chan JM, Carroll P, Cooperberg MR. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer. BJU Int. 2014 Dec; 114(6b):E18-24. PMID: 24712895.
      View in: PubMed
    84. Johnston C, Hilmer SN, McLachlan AJ, Matthews ST, Carroll P, Kirkpatrick CM. The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration. Eur J Clin Pharmacol. 2014 May; 70(5):549-55. PMID: 24522409.
      View in: PubMed
    85. Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll P, Chan JM. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes Control. 2014 Apr; 25(4):515-23. PMID: 24504435; PMCID: PMC3990413.
    86. Anwar M, Westphalen AC, Jung AJ, Noworolski SM, Simko JP, Kurhanewicz J, Roach M, Carroll P, Coakley FV. Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: quantitative analysis of imaging contour compared to whole-mount histopathology. Radiother Oncol. 2014 Feb; 110(2):303-8. PMID: 24444524; PMCID: PMC3969841.
    87. Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R. Overdiagnosis and overtreatment of prostate cancer. Eur Urol. 2014 Jun; 65(6):1046-55. PMID: 24439788; PMCID: PMC4113338.
    88. Sanford MT, Greene KL, Carroll P. The argument for palliative care in prostate cancer. Transl Androl Urol. 2013 Dec; 2(4):278-80. PMID: 26816740.
      View in: PubMed
    89. Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll P. Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort. Urology. 2014 Jan; 83(1):33-8. PMID: 24246319.
      View in: PubMed
    90. Jung AJ, Westphalen AC, Kurhanewicz J, Wang ZJ, Carroll P, Simko JP, Coakley FV. Clinical utility of endorectal MRI-guided prostate biopsy: preliminary experience. J Magn Reson Imaging. 2014 Aug; 40(2):314-23. PMID: 24924999; PMCID: PMC4059791.
    91. Cary KC, Singla N, Cowan JE, Carroll P, Cooperberg MR. Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry. J Urol. 2014 Apr; 191(4):964-70. PMID: 24184370.
      View in: PubMed
    92. Cary KC, Paciorek A, Fuldeore MJ, Carroll P, Cooperberg MR. Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: an analysis from the CaPSURE registry. Cancer. 2014 Feb 15; 120(4):507-12. PMID: 24496867.
      View in: PubMed
    93. Starobinets O, Guo R, Simko JP, Kuchinsky K, Kurhanewicz J, Carroll P, Greene KL, Noworolski SM. Semiautomatic registration of digital histopathology images to in vivo MR images in molded and unmolded prostates. J Magn Reson Imaging. 2014 May; 39(5):1223-9. PMID: 24136783; PMCID: PMC3984354.
    94. Tomaszewski JJ, Richman EL, Sadetsky N, O'Keefe DS, Carroll P, Davies BJ, Chan JM. Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™. J Urol. 2014 Apr; 191(4):971-6. PMID: 24095905.
      View in: PubMed
    95. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJ, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll P, Blackburn EH. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013 Oct; 14(11):1112-20. PMID: 24051140.
      View in: PubMed
    96. Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll P. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies. Eur Urol. 2014 Aug; 66(2):337-42. PMID: 24035632.
      View in: PubMed
    97. Bauer SR, Richman EL, Sosa E, Weinberg V, Song X, Witte JS, Carroll P, Chan JM. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2013 Dec; 73(16):1786-95. PMID: 24038157.
      View in: PubMed
    98. Pfister D, Bolla M, Briganti A, Carroll P, Cozzarini C, Joniau S, van Poppel H, Roach M, Stephenson A, Wiegel T, Zelefsky MJ. Early salvage radiotherapy following radical prostatectomy. Eur Urol. 2014 Jun; 65(6):1034-43. PMID: 23972524.
      View in: PubMed
    99. Punnen S, Clint Cary K, Glass AS, Cowan JE, Carroll P. Autologous retro-pubic urethral sling: a novel, quick, intra-operative technique to improve continence after robotic-assisted radical prostatectomy. J Robot Surg. 2014 Jun; 8(2):99-104. PMID: 27637518.
      View in: PubMed
    100. Broering JM, Paciorek A, Carroll P, Wilson LS, Litwin MS, Miaskowski C. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments. Qual Life Res. 2014 Mar; 23(2):495-508. PMID: 23943258.
      View in: PubMed
    101. Cooperberg MR, Cowan JE, Carroll P. Reply to A. Azad et al. J Clin Oncol. 2013 Sep 10; 31(26):3296-7. PMID: 23943835.
      View in: PubMed
    102. Cary KC, Carroll P. Editorial comment. J Urol. 2013 Oct; 190(4):1223. PMID: 23856519.
      View in: PubMed
    103. Punnen S, Cowan JE, Dunn LB, Shumay DM, Carroll P, Cooperberg MR. A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. BJU Int. 2013 Jul; 112(2):E67-75. PMID: 23795800.
      View in: PubMed
    104. Akaza H, Hinotsu S, Cooperberg MR, Chung BH, Youl Lee J, Umbas R, Tsukamoto T, Namiki M, Carroll P. Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes. Jpn J Clin Oncol. 2013 Jul; 43(7):756-66. PMID: 23723314.
      View in: PubMed
    105. Glass AS, Cowan JE, Fuldeore MJ, Cooperberg MR, Carroll P, Kenfield SA, Greene KL. Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era. Urology. 2013 Jul; 82(1):60-5. PMID: 23706257.
      View in: PubMed
    106. Chang ST, Westphalen AC, Jha P, Jung AJ, Carroll P, Kurhanewicz J, Coakley FV. Endorectal MRI and MR spectroscopic imaging of prostate cancer: developing selection criteria for MR-guided focal therapy. J Magn Reson Imaging. 2014 Mar; 39(3):519-25. PMID: 23681669; PMCID: PMC3748229.
    107. Punnen S, Freedland SJ, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Carroll P, Cooperberg MR. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. Eur Urol. 2014 Jun; 65(6):1171-7. PMID: 23587869.
      View in: PubMed
    108. Odisho AY, Washington SL, Meng MV, Cowan JE, Simko JP, Carroll P. Benign prostate glandular tissue at radical prostatectomy surgical margins. Urology. 2013 Jul; 82(1):154-9. PMID: 23522995; PMCID: PMC3696410.
    109. Lin DW, Newcomb LF, Brown EC, Brooks JD, Carroll P, Feng Z, Gleave ME, Lance RS, Sanda MG, Thompson IM, Wei JT, Nelson PS. Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clin Cancer Res. 2013 May 1; 19(9):2442-50. PMID: 23515404; PMCID: PMC3674574.
    110. Cooperberg MR, Simko JP, Cowan JE, Reid JE, Djalilvand A, Bhatnagar S, Gutin A, Lanchbury JS, Swanson GP, Stone S, Carroll P. Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Clin Oncol. 2013 Apr 10; 31(11):1428-34. PMID: 23460710.
      View in: PubMed
    111. Punnen S, Meng MV, Cooperberg MR, Greene KL, Cowan JE, Carroll P. How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer? BJU Int. 2013 Aug; 112(4):E314-20. PMID: 23451984.
      View in: PubMed
    112. Harris CR, Punnen S, Carroll P. Men with low preoperative sexual function may benefit from nerve sparing radical prostatectomy. J Urol. 2013 Sep; 190(3):981-6. PMID: 23410984.
      View in: PubMed
    113. Glass AS, Porten SP, Bonham M, Tran TC, Cowan JE, Punnen S, Chan JM, Carroll P. Active surveillance: does serial prostate biopsy increase histological inflammation? Prostate Cancer Prostatic Dis. 2013 Jun; 16(2):165-9. PMID: 23318528.
      View in: PubMed
    114. Glass AS, Carroll P. Focal therapy: a new active surveillance tool? Oncology (Williston Park). 2013 Jan 15; 27(1). PMID: 25188237.
      View in: PubMed
    115. Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, Smith E, Tenggara I, Zhang X, Carroll P, Chan JM, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, Feng Z, True LD, Brooks JD. A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray. Adv Anat Pathol. 2013 Jan; 20(1):39-44. PMID: 23232570; PMCID: PMC3535290.
    116. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. Prostate specific antigen best practice statement: 2009 update. J Urol. 2013 Jan; 189(1 Suppl):S2-S11. PMID: 23234625.
      View in: PubMed
    117. Glass AS, Cooperberg MR, Meng MV, Carroll P. Role of active surveillance in the management of localized prostate cancer. J Natl Cancer Inst Monogr. 2012 Dec; 2012(45):202-6. PMID: 23271774; PMCID: PMC3540869.
    118. Eastham JA, Carroll P, Pisters L, Nguyen PT, Touijer K. Salvage therapies after radiation therapy. Urol Oncol. 2012 Nov-Dec; 30(6):940-1. PMID: 23218071.
      View in: PubMed
    119. Xia J, Trock BJ, Cooperberg MR, Gulati R, Zeliadt SB, Gore JL, Lin DW, Carroll P, Carter HB, Etzioni R. Prostate cancer mortality following active surveillance versus immediate radical prostatectomy. Clin Cancer Res. 2012 Oct 1; 18(19):5471-8. PMID: 23008476; PMCID: PMC3604990.
    120. Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll P, Penson DF. Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int. 2013 Feb; 111(2):213-20. PMID: 22928860; PMCID: PMC3540193.
    121. Choe KS, Cowan JE, Chan JM, Carroll P, D'Amico AV, Liauw SL. Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol. 2012 Oct 1; 30(28):3540-4. PMID: 22927523; PMCID: PMC3454771.
    122. Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll P, Konety BR. Reply to Jai Prakash, Apul Goel and Manish Garg's Letter to the Editor re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, Badrinath R. Konety. Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.019. Eur Urol. 2012 Nov; 62(5):e88. PMID: 22921716.
      View in: PubMed
    123. Yang G, Villalta JD, Weiss DA, Carroll P, Breyer BN. Gender differences in academic productivity and academic career choice among urology residents. J Urol. 2012 Oct; 188(4):1286-90. PMID: 22902027; PMCID: PMC3552430.
    124. Hilton JF, Blaschko SD, Whitson JM, Cowan JE, Carroll P. The impact of serial prostate biopsies on sexual function in men on active surveillance for prostate cancer. J Urol. 2012 Oct; 188(4):1252-8. PMID: 22902015.
      View in: PubMed
    125. Bangma CH, Bul M, van der Kwast TH, Pickles T, Korfage IJ, Hoeks CM, Steyerberg EW, Jenster G, Kattan MW, Bellardita L, Carroll P, Denis LJ, Parker C, Roobol MJ, Emberton M, Klotz LH, Rannikko A, Kakehi Y, Lane JA, Schröder FH, Semjonow A, Trock BJ, Valdagni R. Active surveillance for low-risk prostate cancer. Crit Rev Oncol Hematol. 2013 Mar; 85(3):295-302. PMID: 22878262.
      View in: PubMed
    126. Glass AS, Cooperberg MR, Carroll P. Early detection of prostate cancer: more information, more clarity. Eur Urol. 2012 Nov; 62(5):753-5; discussion 755-6. PMID: 22766168.
      View in: PubMed
    127. Kutikov A, Cooperberg MR, Paciorek AT, Uzzo RG, Carroll P, Boorjian SA. Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram. Prostate Cancer Prostatic Dis. 2012 Dec; 15(4):374-9. PMID: 22710832; PMCID: PMC3815610.
    128. Jung AJ, Coakley FV, Shinohara K, Carroll P, Kurhanewicz J, Cowan JE, Westphalen AC. Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound. Clin Imaging. 2012 Sep-Oct; 36(5):547-52. PMID: 22920360; PMCID: PMC3694423.
    129. Dall'Era MA, Albertsen PC, Bangma C, Carroll P, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C, Soloway MS. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol. 2012 Dec; 62(6):976-83. PMID: 22698574.
      View in: PubMed
    130. Montorsi F, Wilson TG, Rosen RC, Ahlering TE, Artibani W, Carroll P, Costello A, Eastham JA, Ficarra V, Guazzoni G, Menon M, Novara G, Patel VR, Stolzenburg JU, Van der Poel H, Van Poppel H, Mottrie A. Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol. 2012 Sep; 62(3):368-81. PMID: 22763081.
      View in: PubMed
    131. Reese AC, Cowan JE, Brajtbord JS, Harris CR, Carroll P, Cooperberg MR. The quantitative Gleason score improves prostate cancer risk assessment. Cancer. 2012 Dec 15; 118(24):6046-54. PMID: 22674220.
      View in: PubMed
    132. Novara G, Ficarra V, Mocellin S, Ahlering TE, Carroll P, Graefen M, Guazzoni G, Menon M, Patel VR, Shariat SF, Tewari AK, Van Poppel H, Zattoni F, Montorsi F, Mottrie A, Rosen RC, Wilson TG. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol. 2012 Sep; 62(3):382-404. PMID: 22749851.
      View in: PubMed
    133. Ficarra V, Novara G, Rosen RC, Artibani W, Carroll P, Costello A, Menon M, Montorsi F, Patel VR, Stolzenburg JU, Van der Poel H, Wilson TG, Zattoni F, Mottrie A. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012 Sep; 62(3):405-17. PMID: 22749852.
      View in: PubMed
    134. Hayes GM, Simko J, Holochwost D, Kuchinsky K, Busch R, Misell L, Murphy EJ, Carroll P, Chan J, Shinohara K, Hellerstein MK. Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid. Clin Cancer Res. 2012 Jun 15; 18(12):3250-60. PMID: 22553345.
      View in: PubMed
    135. Kane A, Mitchell SJ, Carroll P, Matthews S, Hilmer SN. Characteristics of older and younger patients with suspected paracetamol toxicity. Australas J Ageing. 2012 Sep; 31(3):190-3. PMID: 22950592.
      View in: PubMed
    136. Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll P, Konety BR. Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology. Eur Urol. 2013 May; 63(5):936-40. PMID: 22521093; PMCID: PMC3443544.
    137. Berglund RK, Tangen CM, Powell IJ, Lowe BA, Haas GP, Carroll P, Canby-Hagino ED, deVere White R, Hemstreet GP, Crawford ED, Thompson IM, Klein EA. Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109. Urology. 2012 Mar; 79(3):633-7. PMID: 22386416; PMCID: PMC3839235.
    138. Aaronson DS, Odisho AY, Hills N, Cress R, Carroll P, Dudley RA, Cooperberg MR. Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come. Arch Intern Med. 2012 Feb 13; 172(3):280-3. PMID: 22332166.
      View in: PubMed
    139. Arrayeh E, Westphalen AC, Kurhanewicz J, Roach M, Jung AJ, Carroll P, Coakley FV. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82(5):e787-93. PMID: 22331003; PMCID: PMC3285390.
    140. Akaza H, Carroll P, Cooperberg MR, Hinotsu S. Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management. Jpn J Clin Oncol. 2012 Mar; 42(3):226-36. PMID: 22217576.
      View in: PubMed
    141. Cooperberg MR, Odisho AY, Carroll P. Outcomes for radical prostatectomy: is it the singer, the song, or both? J Clin Oncol. 2012 Feb 10; 30(5):476-8. PMID: 22215744.
      View in: PubMed
    142. Messing EM, Albertsen P, Andriole GL, Carroll P, Klein EA. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing. Urol Oncol. 2012 Jan-Feb; 30(1):117-9. PMID: 22243597.
      View in: PubMed
    143. Muglia VF, Westphalen AC, Wang ZJ, Kurhanewicz J, Carroll P, Coakley FV. Endorectal MRI of prostate cancer: incremental prognostic importance of gross locally advanced disease. AJR Am J Roentgenol. 2011 Dec; 197(6):1369-74. PMID: 22109291; PMCID: PMC3703946.
    144. Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll P, Chan JM. PSA screening: determinants of primary-care physician practice patterns. Prostate Cancer Prostatic Dis. 2012 Jun; 15(2):189-94. PMID: 22343837.
      View in: PubMed
    145. Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll P. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer. BJU Int. 2012 Jul; 110(1):50-5. PMID: 22077660.
      View in: PubMed
    146. Reese AC, Fradet V, Whitson JM, Davis CB, Carroll P. Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment. J Urol. 2011 Dec; 186(6):2228-32. PMID: 22014796.
      View in: PubMed
    147. Punnen S, Cooperberg MR, Sadetsky N, Carroll P. Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores? BJU Int. 2012 May; 109(10):1520-4. PMID: 21999368; PMCID: PMC3288727.
    148. Porten SP, Whitson JM, Cowan JE, Perez N, Shinohara K, Carroll P. Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer. J Urol. 2011 Nov; 186(5):1825-9. PMID: 21944082.
      View in: PubMed
    149. Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll P, Sanda MG. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21; 306(11):1205-14. PMID: 21934053; PMCID: PMC3831607.
    150. Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll P, Chan JM. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011; 6(9):e24004. PMID: 21912659; PMCID: PMC3164676.
    151. Richman EL, Carroll P, Chan JM. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer. 2012 Jul 1; 131(1):201-10. PMID: 21823116; PMCID: PMC3310254.
    152. Punnen S, Cooperberg MR, Sadetsky N, Carroll P. Androgen deprivation therapy and cardiovascular risk. J Clin Oncol. 2011 Sep 10; 29(26):3510-6. PMID: 21844498; PMCID: PMC3179251.
    153. Cooperberg MR, Carroll P, Klotz L. Active surveillance for prostate cancer: progress and promise. J Clin Oncol. 2011 Sep 20; 29(27):3669-76. PMID: 21825257.
      View in: PubMed
    154. McKenney JK, Simko J, Bonham M, True LD, Troyer D, Hawley S, Newcomb LF, Fazli L, Kunju LP, Nicolas MM, Vakar-Lopez F, Zhang X, Carroll P, Brooks JD. The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study. J Urol. 2011 Aug; 186(2):465-9. PMID: 21679996.
      View in: PubMed
    155. Cooperberg MR, Mallin K, Kane CJ, Carroll P. Treatment trends for stage I renal cell carcinoma. J Urol. 2011 Aug; 186(2):394-9. PMID: 21679982.
      View in: PubMed
    156. Cooperberg MR, Hilton JF, Carroll P. The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer. 2011 Nov 15; 117(22):5039-46. PMID: 21647869; PMCID: PMC3170662.
    157. Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll P. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol. 2011 Jul 10; 29(20):2795-800. PMID: 21632511.
      View in: PubMed
    158. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll P, Chan JM. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011 Jun 1; 71(11):3889-95. PMID: 21610110; PMCID: PMC3107352.
    159. Ploussard G, Epstein JI, Montironi R, Carroll P, Wirth M, Grimm MO, Bjartell AS, Montorsi F, Freedland SJ, Erbersdobler A, van der Kwast TH. The contemporary concept of significant versus insignificant prostate cancer. Eur Urol. 2011 Aug; 60(2):291-303. PMID: 21601982.
      View in: PubMed
    160. Whitson JM, Porten SP, Cowan JE, Simko JP, Cooperberg MR, Carroll P. Factors associated with downgrading in patients with high grade prostate cancer. Urol Oncol. 2013 May; 31(4):442-7. PMID: 21478037.
      View in: PubMed
    161. Carroll P, Whitson JM. Editorial comment. Urology. 2011 Apr; 77(4):984-5. PMID: 21477729.
      View in: PubMed
    162. Dall'Era MA, Cowan JE, Simko J, Shinohara K, Davies B, Konety BR, Meng MV, Perez N, Greene K, Carroll P. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int. 2011 Apr; 107(8):1232-7. PMID: 20804478.
      View in: PubMed
    163. Whitson JM, Porten SP, Hilton JF, Cowan JE, Perez N, Cooperberg MR, Greene KL, Meng MV, Simko JP, Shinohara K, Carroll P. The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer. J Urol. 2011 May; 185(5):1656-60. PMID: 21419438.
      View in: PubMed
    164. Mallin K, David KA, Carroll P, Milowsky MI, Nanus DM. Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). J Urol. 2011 May; 185(5):1631-6. PMID: 21419456.
      View in: PubMed
    165. Sadetsky N, Greene K, Cooperberg MR, Hubbard A, Carroll P, Satariano W. Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry. Cancer. 2011 Oct 1; 117(19):4406-13. PMID: 21412760.
      View in: PubMed
    166. Porten SP, Cooperberg MR, Konety BR, Carroll P. The example of CaPSURE: lessons learned from a national disease registry. World J Urol. 2011 Jun; 29(3):265-71. PMID: 21347810; PMCID: PMC3099175.
    167. Whitson JM, Porten SP, Carroll P. Prostate cancer: reducing overtreatment: active surveillance in low-risk disease. Nat Rev Urol. 2011 Mar; 8(3):124-5. PMID: 21304508.
      View in: PubMed
    168. Kazer MW, Bailey DE, Colberg J, Kelly WK, Carroll P. The needs for men undergoing active surveillance (AS) for prostate cancer: results of a focus group study. J Clin Nurs. 2011 Feb; 20(3-4):581-6. PMID: 21219530.
      View in: PubMed
    169. Hilmer SN, Tran K, Rubie P, Wright J, Gnjidic D, Mitchell SJ, Matthews S, Carroll P. Gentamicin pharmacokinetics in old age and frailty. Br J Clin Pharmacol. 2011 Feb; 71(2):224-31. PMID: 21219402; PMCID: PMC3040542.
    170. Yang G, Whitson JM, Breyer BN, Konety BR, Carroll P. Oncological and functional outcomes of radical cystectomy and orthotopic bladder replacement in women. Urology. 2011 Apr; 77(4):878-83. PMID: 21215428; PMCID: PMC3607667.
    171. Carroll P, Whitson JM, Cooperberg MR. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes? J Clin Oncol. 2011 Feb 1; 29(4):345-7. PMID: 21189396.
      View in: PubMed
    172. Yang G, Zaid UB, Erickson BA, Blaschko SD, Carroll P, Breyer BN. Urology resident publication output and its relationship to future academic achievement. J Urol. 2011 Feb; 185(2):642-6. PMID: 21168863; PMCID: PMC3565588.
    173. Bechis SK, Carroll P, Cooperberg MR. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol. 2011 Jan 10; 29(2):235-41. PMID: 21135285; PMCID: PMC3058279.
    174. Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll P. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int. 2010 Dec; 106(11):1734-8. PMID: 20438567; PMCID: PMC3565608.
    175. Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll P. Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol. 2011 Jan 10; 29(2):228-34. PMID: 21115873; PMCID: PMC3058278.
    176. Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, Stöppler H, Simko J, Hilton JF, Carroll P, Blelloch R. Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer Res. 2011 Jan 15; 71(2):550-60. PMID: 21098088; PMCID: PMC3022112.
    177. Reese AC, Sadetsky N, Carroll P, Cooperberg MR. Inaccuracies in assignment of clinical stage for localized prostate cancer. Cancer. 2011 Jan 15; 117(2):283-9. PMID: 21210472.
      View in: PubMed
    178. Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll P. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011 Jan; 22(1):141-50. PMID: 21103921; PMCID: PMC3002170.
    179. Cooperberg MR, Vickers AJ, Broering JM, Carroll P. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer. 2010 Nov 15; 116(22):5226-34. PMID: 20690197; PMCID: PMC2975879.
    180. Porten SP, Richardson DA, Odisho AY, McAninch JW, Carroll P, Cooperberg MR. Disproportionate presentation of high risk prostate cancer in a safety net health system. J Urol. 2010 Nov; 184(5):1931-6. PMID: 20846693.
      View in: PubMed
    181. Katz MS, Carroll P, Cowan JE, Chan JM, D'Amico AV. Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE. BJU Int. 2010 Sep; 106(5):627-32. PMID: 20151961.
      View in: PubMed
    182. Tasian GE, Cooperberg MR, Cowan JE, Keyashian K, Greene KL, Daniels NA, Carroll P, Chan JM. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians. Urol Oncol. 2012 Mar-Apr; 30(2):155-60. PMID: 20800514.
      View in: PubMed
    183. Vickers AJ, Salz T, Basch E, Cooperberg MR, Carroll P, Tighe F, Eastham J, Rosen RC. Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship. BMC Med Inform Decis Mak. 2010; 10:34. PMID: 20565745; PMCID: PMC2893444.
    184. Fradet V, Kurhanewicz J, Cowan JE, Karl A, Coakley FV, Shinohara K, Carroll P. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology. 2010 Jul; 256(1):176-83. PMID: 20505068; PMCID: PMC2897693.
    185. Reese AC, Cooperberg MR, Carroll P. Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease. J Urol. 2010 Jul; 184(1):114-9. PMID: 20478578.
      View in: PubMed
    186. Whitson JM, Carroll P. Active surveillance for early-stage prostate cancer: defining the triggers for intervention. J Clin Oncol. 2010 Jun 10; 28(17):2807-9. PMID: 20439633.
      View in: PubMed
    187. Walsh TJ, Schembri M, Turek PJ, Chan JM, Carroll P, Smith JF, Eisenberg ML, Van Den Eeden SK, Croughan MS. Increased risk of high-grade prostate cancer among infertile men. Cancer. 2010 May 1; 116(9):2140-7. PMID: 20309846; PMCID: PMC2893877.
    188. Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll P. Urologist density and county-level urologic cancer mortality. J Clin Oncol. 2010 May 20; 28(15):2499-504. PMID: 20406931; PMCID: PMC2881728.
    189. Fang AC, Ahmad AE, Whitson JM, Ferrell LD, Carroll P, Konety BR. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer. 2010 Apr 15; 116(8):1901-8. PMID: 20186823.
      View in: PubMed
    190. Katz MS, Efstathiou JA, D'Amico AV, Kattan MW, Sanda MG, Nguyen PL, Smith MR, Carroll P, Zietman AL. The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer. BJU Int. 2010 May; 105(10):1417-22. PMID: 20346051; PMCID: PMC3090683.
    191. Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, Kennedy MJ, Connolly E, Reynolds JV. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol). 2010 May; 22(4):281-8. PMID: 20189371.
      View in: PubMed
    192. Le JD, Cooperberg MR, Sadetsky N, Hittelman AB, Meng MV, Cowan JE, Latini DM, Carroll P. Changes in specific domains of sexual function and sexual bother after radical prostatectomy. BJU Int. 2010 Oct; 106(7):1022-9. PMID: 20184571.
      View in: PubMed
    193. Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll P, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw. 2010 Feb; 8(2):240-62. PMID: 20141680.
      View in: PubMed
    194. Cooperberg MR, Broering JM, Carroll P. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010 Mar 1; 28(7):1117-23. PMID: 20124165; PMCID: PMC2834465.
    195. Moses KA, Paciorek AT, Penson DF, Carroll P, Master VA. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol. 2010 Feb 20; 28(6):1069-74. PMID: 20100957; PMCID: PMC2834431.
    196. Smaldone MC, Cowan JE, Carroll P, Davies BJ. Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort. J Urol. 2010 Jan; 183(1):138-43. PMID: 19913808.
      View in: PubMed
    197. Doyle SM, Kahn JG, Hosang N, Carroll P. The impact of male circumcision on HIV transmission. J Urol. 2010 Jan; 183(1):21-6. PMID: 19913816.
      View in: PubMed
    198. Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll P, Chan JM. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010 Mar; 91(3):712-21. PMID: 20042525; PMCID: PMC3132069.
    199. Santos CF, Kurhanewicz J, Tabatabai ZL, Simko JP, Keshari KR, Gbegnon A, Santos RD, Federman S, Shinohara K, Carroll P, Haqq CM, Swanson MG. Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. NMR Biomed. 2010 May; 23(4):391-8. PMID: 20033906; PMCID: PMC2891902.
    200. Paris PL, Weinberg V, Albo G, Roy R, Burke C, Simko J, Carroll P, Collins C. A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer. Clin Cancer Res. 2010 Jan 1; 16(1):195-202. PMID: 20028763; PMCID: PMC2854027.
    201. Carroll P. Editorial comment. J Urol. 2010 Feb; 183(2):564. PMID: 20018313.
      View in: PubMed
    202. Aaronson D, Cowan J, Carroll P, Konety B. Association of age and response to androgen-deprivation therapy with or without radiotherapy for prostate cancer: data from CaPSURE. BJU Int. 2010 Apr; 105(7):951-5. PMID: 19889066.
      View in: PubMed
    203. Eisenberg ML, Cowan JE, Carroll P, Shinohara K. The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer. BJU Int. 2010 May; 105(9):1237-41. PMID: 19888980.
      View in: PubMed
    204. Whitson JM, Berry AB, Carroll P, Konety BR. UroVysion testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer. Int Braz J Urol. 2009 Nov-Dec; 35(6):664-70; discussion 671-2. PMID: 20028572.
      View in: PubMed
    205. Lin GA, Aaronson DS, Knight SJ, Carroll P, Dudley RA. Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin. 2009 Nov-Dec; 59(6):379-90. PMID: 19841280.
      View in: PubMed
    206. Abouassaly R, Paciorek A, Ryan CJ, Carroll P, Klein EA. Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE. Cancer. 2009 Oct 1; 115(19):4470-6. PMID: 19637339.
      View in: PubMed
    207. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. Prostate specific antigen best practice statement: 2009 update. J Urol. 2009 Nov; 182(5):2232-41. PMID: 19781717.
      View in: PubMed
    208. Bailey DE, Wallace M, Latini DM, Hegarty J, Carroll P, Klein EA, Albertsen PC. Measuring illness uncertainty in men undergoing active surveillance for prostate cancer. Appl Nurs Res. 2011 Nov; 24(4):193-9. PMID: 20974073; PMCID: PMC3070758.
    209. Newcomb LF, Brooks JD, Carroll P, Feng Z, Gleave ME, Nelson PS, Thompson IM, Lin DW. Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository. Urology. 2010 Feb; 75(2):407-13. PMID: 19758683; PMCID: PMC3827723.
    210. Sadetsky N, Hubbard A, Carroll P, Satariano W. Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database. Qual Life Res. 2009 Oct; 18(8):1019-27. PMID: 19697155; PMCID: PMC2744792.
    211. Porten SP, Cooperberg MR, Carroll P. The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease. BJU Int. 2010 Feb; 105(4):472-5. PMID: 19681901; PMCID: PMC2821458.
    212. Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll P, Akaza H. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J Clin Oncol. 2009 Sep 10; 27(26):4306-13. PMID: 19667269; PMCID: PMC2744272.
    213. Cooperberg MR, Carroll P. Prostate-cancer screening. N Engl J Med. 2009 Jul 9; 361(2):203; author reply 204-5. PMID: 19593852.
      View in: PubMed
    214. Cooperberg MR, Kane CJ, Cowan JE, Carroll P. Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy. BJU Int. 2010 Jan; 105(1):88-92. PMID: 19549119.
      View in: PubMed
    215. Cooperberg MR, Broering JM, Carroll P. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst. 2009 Jun 16; 101(12):878-87. PMID: 19509351; PMCID: PMC2697208.
    216. Davies BJ, Smaldone MC, Sadetsky N, Dall'era M, Carroll P. The impact of obesity on overall and cancer specific survival in men with prostate cancer. J Urol. 2009 Jul; 182(1):112-7; discussion 117. PMID: 19447437.
      View in: PubMed
    217. Dall'Era MA, Carroll P. Outcomes and follow-up strategies for patients on active surveillance. Curr Opin Urol. 2009 May; 19(3):258-62. PMID: 19295434.
      View in: PubMed
    218. Michalski JM, Roach M, Merrick G, Anscher MS, Beyer DC, Lawton CA, Lee WR, Pollack A, Rosenthal SA, Vijayakumar S, Carroll P. ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate. Int J Radiat Oncol Biol Phys. 2009 Jul 1; 74(3):667-72. PMID: 19386445.
      View in: PubMed
    219. Eisenberg ML, Cowan JE, Davies BJ, Carroll P, Shinohara K. The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer. Urol Oncol. 2011 Mar-Apr; 29(2):171-6. PMID: 19362864.
      View in: PubMed
    220. Eisenberg ML, Davies BJ, Cooperberg MR, Cowan JE, Carroll P. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol. 2010 Apr; 57(4):622-9. PMID: 19375843; PMCID: PMC2930030.
    221. David KA, Mallin K, Milowsky MI, Ritchey J, Carroll P, Nanus DM. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000. Cancer. 2009 Apr 1; 115(7):1435-47. PMID: 19215030.
      View in: PubMed
    222. Ross PL, Cheng I, Liu X, Cicek MS, Carroll P, Casey G, Witte JS. Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer. BMC Cancer. 2009; 9:69. PMID: 19245716; PMCID: PMC2657151.
    223. Conti SL, Dall'era M, Fradet V, Cowan JE, Simko J, Carroll P. Pathological outcomes of candidates for active surveillance of prostate cancer. J Urol. 2009 Apr; 181(4):1628-33; discussion 1633-4. PMID: 19233388.
      View in: PubMed
    224. Dall'era MA, Hosang N, Konety B, Cowan JE, Carroll P. Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease. J Urol. 2009 Apr; 181(4):1622-7; discussion 1627. PMID: 19230923.
      View in: PubMed
    225. Chen RC, Sadetsky N, Chen MH, Carroll P, D'Amico AV. Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy. Int J Radiat Oncol Biol Phys. 2009 Sep 1; 75(1):36-9. PMID: 19233568.
      View in: PubMed
    226. Whitson J, Berry A, Carroll P, Konety B. A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy. BJU Int. 2009 Aug; 104(3):336-9. PMID: 19220253.
      View in: PubMed
    227. Konety BR, Cooperberg MR, Carroll P. Are age-based criteria the best way to determine eligibility for prostate cancer screening? Ann Intern Med. 2009 Feb 3; 150(3):220-1; author reply 221-2. PMID: 19189916.
      View in: PubMed
    228. Breyer BN, Whitson JM, Carroll P, Konety BR. Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer. Urol Oncol. 2010 Sep-Oct; 28(5):510-4. PMID: 19171491; PMCID: PMC3565601.
    229. Karl A, Carroll P, Gschwend JE, Knüchel R, Montorsi F, Stief CG, Studer UE. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol. 2009 Apr; 55(4):826-35. PMID: 19150582.
      View in: PubMed
    230. Odisho AY, Fradet V, Cooperberg MR, Ahmad AE, Carroll P. Geographic distribution of urologists throughout the United States using a county level approach. J Urol. 2009 Feb; 181(2):760-5; discussion 765-6. PMID: 19091334.
      View in: PubMed
    231. Zerbib M, Zelefsky MJ, Higano CS, Carroll P. Conventional treatments of localized prostate cancer. Urology. 2008 Dec; 72(6 Suppl):S25-35. PMID: 19095125.
      View in: PubMed
    232. Marberger M, Carroll P, Zelefsky MJ, Coleman JA, Hricak H, Scardino PT, Abenhaim LL. New treatments for localized prostate cancer. Urology. 2008 Dec; 72(6 Suppl):S36-43. PMID: 19095127.
      View in: PubMed
    233. Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll P, Rubin MA, Scardino PT. Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology. 2008 Dec; 72(6 Suppl):S12-24. PMID: 19095124.
      View in: PubMed
    234. Simone NL, Singh AK, Cowan JE, Soule BP, Carroll P, Litwin MS. Pretreatment predictors of death from other causes in men with prostate cancer. J Urol. 2008 Dec; 180(6):2447-51; discussion 2451-2. PMID: 18930498; PMCID: PMC3013289.
    235. White WM, Sadetsky N, Waters WB, Carroll P, Litwin MS. Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database. J Urol. 2008 Dec; 180(6):2409-13; discussion 2414. PMID: 18930270.
      View in: PubMed
    236. Wu AK, Cooperberg MR, Sadetsky N, Carroll P. Health related quality of life in patients treated with multimodal therapy for prostate cancer. J Urol. 2008 Dec; 180(6):2415-22; discussion 2422. PMID: 18930279.
      View in: PubMed
    237. Isbarn H, Boccon-Gibod L, Carroll P, Montorsi F, Schulman C, Smith MR, Sternberg CN, Studer UE. Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. Eur Urol. 2009 Jan; 55(1):62-75. PMID: 18945543; PMCID: PMC3090670.
    238. Hong YM, Hu JC, Paciorek AT, Knight SJ, Carroll P. Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: results from CaPSURE. Urol Oncol. 2010 May-Jun; 28(3):268-73. PMID: 18848785.
      View in: PubMed
    239. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, Magbanua MJ, Marlin R, Yglecias L, Carroll P, Blackburn EH. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008 Nov; 9(11):1048-57. PMID: 18799354.
      View in: PubMed
    240. Paris PL, Sridharan S, Hittelman AB, Kobayashi Y, Perner S, Huang G, Simko J, Carroll P, Rubin MA, Collins C. An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer. Prostate Cancer Prostatic Dis. 2009; 12(2):184-91. PMID: 18779856; PMCID: PMC2844124.
    241. Barocas DA, Cowan JE, Smith JA, Carroll P. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol. 2008 Oct; 180(4):1330-4; discussion 1334-5. PMID: 18707731.
      View in: PubMed
    242. Frattaroli J, Weidner G, Dnistrian AM, Kemp C, Daubenmier JJ, Marlin RO, Crutchfield L, Yglecias L, Carroll P, Ornish D. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology. 2008 Dec; 72(6):1319-23. PMID: 18602144.
      View in: PubMed
    243. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll P. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008 Jul 1; 113(1):78-83. PMID: 18491376.
      View in: PubMed
    244. Swanson MG, Keshari KR, Tabatabai ZL, Simko JP, Shinohara K, Carroll P, Zektzer AS, Kurhanewicz J. Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magn Reson Med. 2008 Jul; 60(1):33-40. PMID: 18581409; PMCID: PMC2643975.
    245. Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll P. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A. 2008 Jun 17; 105(24):8369-74. PMID: 18559852; PMCID: PMC2430265.
    246. Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll P. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer. 2008 Jun 15; 112(12):2664-70. PMID: 18433013.
      View in: PubMed
    247. Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll P, Kane CJ. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004. J Urol. 2008 Jun; 179(6):2131-5. PMID: 18423754.
      View in: PubMed
    248. Arredondo SA, Downs TM, Lubeck DP, Pasta DJ, Silva SJ, Wallace KL, Carroll P. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol. 2008 May; 179(5 Suppl):S14-8. PMID: 18405740.
      View in: PubMed
    249. Cabrera AR, Coakley FV, Westphalen AC, Lu Y, Zhao S, Shinohara K, Carroll P, Kurhanewicz J. Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance? Radiology. 2008 May; 247(2):444-50. PMID: 18430877; PMCID: PMC3705558.
    250. Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE, Wallace ME, Kantoff PW, Carroll P. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer. 2008 Apr 15; 112(8):1650-9. PMID: 18306379.
      View in: PubMed
    251. Cooperberg MR, Cowan J, Broering JM, Carroll P. High-risk prostate cancer in the United States, 1990-2007. World J Urol. 2008 Jun; 26(3):211-8. PMID: 18369637; PMCID: PMC2948572.
    252. Walsh TJ, Davies BJ, Croughan MS, Carroll P, Turek PJ. Racial differences among boys with testicular germ cell tumors in the United States. J Urol. 2008 May; 179(5):1961-5. PMID: 18355842.
      View in: PubMed
    253. Woldrich JM, Mallin K, Ritchey J, Carroll P, Kane CJ. Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004. J Urol. 2008 May; 179(5):1709-13; discussion 1713. PMID: 18343430.
      View in: PubMed
    254. Konety BR, Cowan JE, Carroll P. Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE. J Urol. 2008 May; 179(5):1797-803; discussion 1803. PMID: 18343440.
      View in: PubMed
    255. Bellizzi KM, Latini DM, Cowan JE, DuChane J, Carroll P. Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology. 2008 Dec; 72(6):1269-73. PMID: 18342930.
      View in: PubMed
    256. Sadetsky N, Lubeck DP, Pasta DJ, Latini DM, DuChane J, Carroll P. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor. BJU Int. 2008 Mar; 101(6):691-7. PMID: 18291018.
      View in: PubMed
    257. Davies BJ, Walsh TJ, Ross PL, Knight SJ, Sadetsky N, Carroll P, Kane CJ. Effect of BMI on primary treatment of prostate cancer. Urology. 2008 Aug; 72(2):406-11. PMID: 18267336.
      View in: PubMed
    258. Choueiri TK, Dreicer R, Paciorek A, Carroll P, Konety B. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy. J Urol. 2008 Mar; 179(3):906-10; discussion 910. PMID: 18207194.
      View in: PubMed
    259. Lee IH, Sadetsky N, Carroll P, Sandler HM. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors. J Urol. 2008 Mar; 179(3):1072-6; discussion 1076. PMID: 18206926.
      View in: PubMed
    260. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll P. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer. 2008 Jan 15; 112(2):307-14. PMID: 18050294.
      View in: PubMed
    261. Kurhanewicz J, Vigneron D, Carroll P, Coakley F. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol. 2008 Jan; 18(1):71-7. PMID: 18090494; PMCID: PMC2804482.
    262. Chung CS, Chen MH, Cullen J, McLeod D, Carroll P, D'Amico AV. Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality. Urology. 2008 Jan; 71(1):136-40. PMID: 18242382.
      View in: PubMed
    263. Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll P. Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database. Urol Oncol. 2008 May-Jun; 26(3):271-5. PMID: 18452818.
      View in: PubMed
    264. Scales CD, Moul JW, Curtis LH, Elkin EP, Hughes ME, Carroll P. Prostate cancer in the Baby Boomer generation: results from CaPSURE. Urology. 2007 Dec; 70(6):1162-7. PMID: 18158039.
      View in: PubMed
    265. Westphalen AC, Coakley FV, Qayyum A, Swanson M, Simko JP, Lu Y, Zhao S, Carroll P, Yeh BM, Kurhanewicz J. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology. 2008 Jan; 246(1):177-84. PMID: 18024434.
      View in: PubMed
    266. Shah JB, McKiernan JM, Elkin EP, Carroll P, Meng MV. Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy. J Urol. 2008 Jan; 179(1):136-40. PMID: 17997437.
      View in: PubMed
    267. Eggener SE, Scardino PT, Carroll P, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol. 2007 Dec; 178(6):2260-7. PMID: 17936815.
      View in: PubMed
    268. Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll P. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst. 2007 Oct 17; 99(20):1516-24. PMID: 17925537.
      View in: PubMed
    269. Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll P. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database. Prostate Cancer Prostatic Dis. 2008; 11(3):280-7. PMID: 17893700.
      View in: PubMed
    270. Walsh TJ, Dall'Era MA, Croughan MS, Carroll P, Turek PJ. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol. 2007 Oct; 178(4 Pt 1):1440-6; discussion 1446. PMID: 17706709.
      View in: PubMed
    271. Alexander BM, Chen MH, Carroll P, D'Amico AV. Prostate-specific antigen level at initiation of hormonal therapy after prostate-specific antigen failure following prostatectomy or radiotherapy and therapeutic response. Urology. 2007 Aug; 70(2):320-3. PMID: 17826497.
      View in: PubMed
    272. Kawachi MH, Bahnson RR, Barry M, Carroll P, Carter HB, Catalona WJ, Epstein JI, Etzioni RB, Hemstreet GP, Howe RJ, Kopin JD, Lange PH, Lilja H, Mohler J, Moul J, Nadler RB, Patterson S, Pollack A, Presti JC, Stroup AM, Urban DA, Wake R, Wei JT. Prostate cancer early detection. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2007 Aug; 5(7):714-36. PMID: 17692177.
      View in: PubMed
    273. Cooperberg MR, Broering JM, Kantoff PW, Carroll P. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007 Sep; 178(3 Pt 2):S14-9. PMID: 17644125; PMCID: PMC2987559.
    274. Kantoff PW, Beer TM, D'Amico AV, Dipaola RS, Eisenberger MA, Hussain MH, Kelly WK, Mathew P, Morris MJ, Ryan CJ, Sandler HM, Thompson IM, Carroll P. Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge Conference. J Urol. 2007 Sep; 178(3 Pt 2):S5-8; quiz S4. PMID: 17644118.
      View in: PubMed
    275. Hart SL, Latini DM, Cowan JE, Carroll P. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer. 2008 Feb; 16(2):161-9. PMID: 17638026.
      View in: PubMed
    276. Latini DM, Hart SL, Knight SJ, Cowan JE, Ross PL, Duchane J, Carroll P. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol. 2007 Sep; 178(3 Pt 1):826-31; discussion 831-2. PMID: 17632144.
      View in: PubMed
    277. Ryan CJ, Elkin EP, Cowan J, Carroll P. Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE. Cancer. 2007 Jul 1; 110(1):81-6. PMID: 17516446.
      View in: PubMed
    278. Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll P. Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database. Urology. 2007 Jul; 70(1):106-10. PMID: 17656218.
      View in: PubMed
    279. Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll P. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE. J Urol. 2007 Aug; 178(2):529-34; discussion 534. PMID: 17570425.
      View in: PubMed
    280. David KA, Milowsky MI, Ritchey J, Carroll P, Nanus DM. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol. 2007 Aug; 178(2):451-4. PMID: 17561135.
      View in: PubMed
    281. Wright JL, Lin DW, Cowan JE, Carroll P, Litwin MS. Quality of life in young men after radical prostatectomy. Prostate Cancer Prostatic Dis. 2008; 11(1):67-73. PMID: 17519925.
      View in: PubMed
    282. Dall'Era M, Carroll P. Prostate cancer--more information and more questions. J Urol. 2007 May; 177(5):1607-8. PMID: 17437768.
      View in: PubMed
    283. Knight SJ, Latini DM, Hart SL, Sadetsky N, Kane CJ, DuChane J, Carroll P. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE. Cancer. 2007 May 1; 109(9):1769-76. PMID: 17380491.
      View in: PubMed
    284. D'Amico AV, McLeod DG, Carroll P, Cullen J, Chen MH. Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality. Cancer. 2007 Apr 1; 109(7):1290-5. PMID: 17315162.
      View in: PubMed
    285. Konety BR, Sadetsky N, Carroll P. Recovery of urinary continence following radical prostatectomy: the impact of prostate volume--analysis of data from the CaPSURE Database. J Urol. 2007 Apr; 177(4):1423-5; discussion 1425-6. PMID: 17382745.
      View in: PubMed
    286. Lee WR, Sharkey J, Cowan JE, DuChane J, Carroll P. Prostate brachytherapy: a descriptive analysis from CaPSURE. Brachytherapy. 2007 Apr-Jun; 6(2):123-8. PMID: 17434105.
      View in: PubMed
    287. Boorjian S, Cowan JE, Konety BR, DuChane J, Tewari A, Carroll P, Kane CJ. Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2007 Mar; 177(3):883-7; discussion 887-8. PMID: 17296367.
      View in: PubMed
    288. Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll P. Cumulative cost pattern comparison of prostate cancer treatments. Cancer. 2007 Feb 1; 109(3):518-27. PMID: 17186528.
      View in: PubMed
    289. Konety BR, Allareddy V, Carroll P. Factors affecting outcomes after radical cystectomy in African Americans. Cancer. 2007 Feb 1; 109(3):542-8. PMID: 17200961.
      View in: PubMed
    290. Berglund RK, Sadetsky N, DuChane J, Carroll P, Klein EA. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE. J Urol. 2007 Feb; 177(2):526-29; discussion 529-30. PMID: 17222625.
      View in: PubMed
    291. Dewell A, Weidner G, Sumner MD, Barnard RJ, Marlin RO, Daubenmier JJ, Chi C, Carroll P, Ornish D. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial. Nutr Cancer. 2007; 58(1):35-42. PMID: 17571965.
      View in: PubMed
    292. Arredondo SA, Latini DM, Sadetsky N, Kawakami J, Pasta DJ, DuChane J, Carroll P. Quality of life for men receiving a second treatment for prostate cancer. J Urol. 2007 Jan; 177(1):273-8; discussion 278-9. PMID: 17162062.
      View in: PubMed
    293. Coakley FV, Chen I, Qayyum A, Westphalen AC, Carroll P, Hricak H, Chen MH, Kurhanewicz J. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging. BJU Int. 2007 Jan; 99(1):41-5. PMID: 17227490.
      View in: PubMed
    294. Hom JJ, Coakley FV, Simko JP, Lu Y, Qayyum A, Westphalen AC, Schmitt LD, Carroll P, Kurhanewicz J. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience. Radiology. 2007 Feb; 242(2):483-9. PMID: 17179396.
      View in: PubMed
    295. Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll P. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology. 2006 Dec; 68(6):1242-7. PMID: 17141841.
      View in: PubMed
    296. Tsai HK, Chen MH, McLeod DG, Carroll P, Richie JP, D'Amico AV. Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer. Cancer. 2006 Dec 1; 107(11):2597-603. PMID: 17039498.
      View in: PubMed
    297. Paris PL, Hofer MD, Albo G, Kuefer R, Gschwend JE, Hautmann RE, Fridyland J, Simko J, Carroll P, Rubin MA, Collins C. Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer. Neoplasia. 2006 Dec; 8(12):1083-9. PMID: 17217626; PMCID: PMC1783716.
    298. Thompson IM, Carroll P, Carducci MA. Recommendations for defining and treating high risk localized prostate cancer. J Urol. 2006 Dec; 176(6 Pt 2):S6-S10; quiz S3-5. PMID: 17084170.
      View in: PubMed
    299. Cooperberg MR, Freedland SJ, Pasta DJ, Elkin EP, Presti JC, Amling CL, Terris MK, Aronson WJ, Kane CJ, Carroll P. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer. 2006 Nov 15; 107(10):2384-91. PMID: 17039503.
      View in: PubMed
    300. Kawakami J, Meng MV, Sadetsky N, Latini DM, Duchane J, Carroll P. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. J Urol. 2006 Oct; 176(4 Pt 1):1382-6. PMID: 16952638.
      View in: PubMed
    301. Ryan CJ, Elkin EP, Small EJ, Duchane J, Carroll P. Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE. Urol Oncol. 2006 Sep-Oct; 24(5):396-402. PMID: 16962488.
      View in: PubMed
    302. Efstathiou JA, Chen MH, Catalona WJ, McLeod DG, Carroll P, Moul JW, Roehl KA, D'Amico AV. Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality. Urology. 2006 Aug; 68(2):342-7. PMID: 16904449.
      View in: PubMed
    303. Eisenberg MS, Meng MV, Master VA, Stoller ML, Rini BI, Carroll P, Kane CJ. Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma. J Endourol. 2006 Jul; 20(7):504-8. PMID: 16859465.
      View in: PubMed
    304. Meng MV, Elkin EP, DuChane J, Carroll P. Impact of increased number of biopsies on the nature of prostate cancer identified. J Urol. 2006 Jul; 176(1):63-8; discussion 69. PMID: 16753368.
      View in: PubMed
    305. Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, Schmitt L, Carroll P, Shinohara K, Vigneron DB, Kurhanewicz J. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med. 2006 Jun; 55(6):1257-64. PMID: 16685733.
      View in: PubMed
    306. Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll P. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Cancer. 2006 Apr 15; 106(8):1708-14. PMID: 16544313.
      View in: PubMed
    307. Marr PL, Elkin EP, Arredondo SA, Broering JM, DuChane J, Carroll P. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE. J Urol. 2006 Apr; 175(4):1326-31. PMID: 16515991.
      View in: PubMed
    308. Arredondo SA, Elkin EP, Marr PL, Latini DM, DuChane J, Litwin MS, Carroll P. Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE. Urology. 2006 Mar; 67(3):559-65. PMID: 16527580.
      View in: PubMed
    309. Carroll P. Modifying urology residency training: time to speed up or slow down? J Urol. 2006 Mar; 175(3 Pt 1):811-2. PMID: 16469555.
      View in: PubMed
    310. Latini DM, Elkin EP, Cooperberg MR, Sadetsky N, Duchane J, Carroll P. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE. Cancer. 2006 Feb 15; 106(4):789-95. PMID: 16400651.
      View in: PubMed
    311. Penfold J, Staples E, Tucker I, Carroll P, Clayton I, Cowan JS, Lawton G, Amin S, Ferrante A, Ruddock N. Elongational flow induced ordering in surfactant micelles and mesophases. J Phys Chem B. 2006 Jan 19; 110(2):1073-82. PMID: 16471644.
      View in: PubMed
    312. Carroll P, Coakley FV, Kurhanewicz J. Magnetic resonance imaging and spectroscopy of prostate cancer. Rev Urol. 2006; 8 Suppl 1:S4-S10. PMID: 17021625; PMCID: PMC1578527.
    313. Hom JJ, Coakley FV, Simko JP, Qayyum A, Lu Y, Schmitt L, Carroll P, Kurhanewicz J. Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions. Radiology. 2006 Jan; 238(1):192-9. PMID: 16373767.
      View in: PubMed
    314. Enokida H, Shiina H, Urakami S, Terashima M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll P, Igawa M, Dahiya R. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer. 2006 Jan 1; 106(1):79-86. PMID: 16323173.
      View in: PubMed
    315. Greene KL, Elkin EP, Karapetian A, Duchane J, Carroll P, Kane CJ. Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE. J Urol. 2006 Jan; 175(1):125-9; discussion 129. PMID: 16406887.
      View in: PubMed
    316. Daubenmier JJ, Weidner G, Marlin R, Crutchfield L, Dunn-Emke S, Chi C, Gao B, Carroll P, Ornish D. Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology. 2006 Jan; 67(1):125-30. PMID: 16413347.
      View in: PubMed
    317. Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll P. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005 Dec; 66(6):1223-8. PMID: 16360447.
      View in: PubMed
    318. Cooperberg MR, Moul JW, Carroll P. The changing face of prostate cancer. J Clin Oncol. 2005 Nov 10; 23(32):8146-51. PMID: 16278465.
      View in: PubMed
    319. Master VA, Chi T, Simko JP, Weinberg V, Carroll P. The independent impact of extended pattern biopsy on prostate cancer stage migration. J Urol. 2005 Nov; 174(5):1789-93; discussion 1793. PMID: 16217288.
      View in: PubMed
    320. Park S, Meng MV, Elkin EP, Speight JL, DuChane J, Carroll P. Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE. J Urol. 2005 Nov; 174(5):1802-7. PMID: 16217291.
      View in: PubMed
    321. Greene KL, Cowan JE, Cooperberg MR, Meng MV, DuChane J, Carroll P. Who is the average patient presenting with prostate cancer? Urology. 2005 Nov; 66(5 Suppl):76-82. PMID: 16194711.
      View in: PubMed
    322. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll P, Kane CJ. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology. 2005 Nov; 66(5):1060-5. PMID: 16286124.
      View in: PubMed
    323. Ogishima T, Shiina H, Breault JE, Terashima M, Honda S, Enokida H, Urakami S, Tokizane T, Kawakami T, Ribeiro-Filho LA, Fujime M, Kane CJ, Carroll P, Igawa M, Dahiya R. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene. 2005 Oct 13; 24(45):6765-72. PMID: 16007175.
      View in: PubMed
    324. Haqq C, Li R, Khodabakhsh D, Frolov A, Ginzinger D, Thompson T, Wheeler T, Carroll P, Ayala G. Ethnic and racial differences in prostate stromal estrogen receptor alpha. Prostate. 2005 Oct 1; 65(2):101-9. PMID: 15880569.
      View in: PubMed
    325. Zhou P, Chen MH, McLeod D, Carroll P, Moul JW, D'Amico AV. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol. 2005 Oct 1; 23(28):6992-8. PMID: 16192586.
      View in: PubMed
    326. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM. Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res. 2005 Oct 1; 11(19 Pt 1):7012-22. PMID: 16203795.
      View in: PubMed
    327. Stewart AJ, Scher HI, Chen MH, McLeod DG, Carroll P, Moul JW, D'Amico AV. Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure. J Clin Oncol. 2005 Sep 20; 23(27):6556-60. PMID: 16170163.
      View in: PubMed
    328. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll P, Dahiya R. Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res. 2005 Sep 15; 11(18):6582-8. PMID: 16166436.
      View in: PubMed
    329. Chan JM, Latini DM, Cowan J, Duchane J, Carroll P. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control. 2005 Sep; 16(7):789-97. PMID: 16132789.
      View in: PubMed
    330. Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ, Dunn-Emke S, Crutchfield L, Jacobs FN, Barnard RJ, Aronson WJ, McCormac P, McKnight DJ, Fein JD, Dnistrian AM, Weinstein J, Ngo TH, Mendell NR, Carroll P. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005 Sep; 174(3):1065-9; discussion 1069-70. PMID: 16094059.
      View in: PubMed
    331. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Pookot D, Li LC, Tabatabai ZL, Kawahara M, Nakagawa M, Kane CJ, Carroll P, Dahiya R. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer. 2005 Aug 20; 116(2):174-81. PMID: 15800905.
      View in: PubMed
    332. Master VA, Gottschalk AR, Kane C, Carroll P. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol. 2005 Aug; 174(2):473-7; discussion 477. PMID: 16006867.
      View in: PubMed
    333. Langenstroer P, Carroll P, Thrasher JB. Clinical and pathological characteristics of unstageable prostate cancer: analysis of the CaPSURE database. J Urol. 2005 Jul; 174(1):118-20. PMID: 15947594.
      View in: PubMed
    334. Rosenberg JE, Carroll P, Small EJ. Update on chemotherapy for advanced bladder cancer. J Urol. 2005 Jul; 174(1):14-20. PMID: 15947569.
      View in: PubMed
    335. Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer. 2005 Jul 1; 104(1):44-52. PMID: 15895377.
      View in: PubMed
    336. Paris PL, Weinberg V, Simko J, Andaya A, Albo G, Rubin MA, Carroll P, Collins C. Preliminary evaluation of prostate cancer metastatic risk biomarkers. Int J Biol Markers. 2005 Jul-Sep; 20(3):141-5. PMID: 16247872.
      View in: PubMed
    337. Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K, Devries S, Koppie T, Pejavar S, Carroll P, Waldman FM. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res. 2005 Jun 1; 11(11):4044-55. PMID: 15930339.
      View in: PubMed
    338. Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll P. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005 Jun; 173(6):1938-42. PMID: 15879786; PMCID: PMC2948569.
    339. D'Amico AV, Moul J, Carroll P, Sun L, Lubeck D, Chen MH. Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer. J Urol. 2005 May; 173(5):1572-6. PMID: 15821488.
      View in: PubMed
    340. Carducci MA, Carroll P. Multidisciplinary management of advanced prostate cancer: changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials. Urology. 2005 May; 65(5 Suppl):18-22; discussion 22. PMID: 15885275.
      View in: PubMed
    341. Meng MV, Elkin EP, Latini DM, Duchane J, Carroll P. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE). J Urol. 2005 May; 173(5):1557-61. PMID: 15821485.
      View in: PubMed
    342. Carroll P. Early stage prostate cancer--do we have a problem with over-detection, overtreatment or both? J Urol. 2005 Apr; 173(4):1061-2. PMID: 15758699.
      View in: PubMed
    343. Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll P. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE. J Urol. 2005 Apr; 173(4):1126-31. PMID: 15758720.
      View in: PubMed
    344. Anast JW, Sadetsky N, Pasta DJ, Bassett WW, Latini D, DuChane J, Chan JM, Cooperberg MR, Carroll P, Kane CJ. The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). J Urol. 2005 Apr; 173(4):1132-8. PMID: 15758721.
      View in: PubMed
    345. Retz MM, Sidhu SS, Blaveri E, Kerr SC, Dolganov GM, Lehmann J, Carroll P, Simko J, Waldman FM, Basbaum C. CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. Int J Cancer. 2005 Mar 20; 114(2):182-9. PMID: 15540205.
      View in: PubMed
    346. Shiina H, Breault JE, Basset WW, Enokida H, Urakami S, Li LC, Okino ST, Deguchi M, Kaneuchi M, Terashima M, Yoneda T, Shigeno K, Carroll P, Igawa M, Dahiya R. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res. 2005 Mar 15; 65(6):2130-8. PMID: 15781623.
      View in: PubMed
    347. Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll P. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. J Urol. 2005 Mar; 173(3):732-6. PMID: 15711258.
      View in: PubMed
    348. Sheriff SK, Shohara RA, Dumican SB, Small EJ, Carroll P, Chan JM. Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancer. Clin Prostate Cancer. 2005 Mar; 3(4):239-45. PMID: 15882480.
      View in: PubMed
    349. Sadetsky N, Lubeck DP, Latini DM, Pasta DJ, Kawakami J, DuChane J, Carroll P. Demographics, insurance coverage, and utilization of medical services in newly diagnosed prostate cancer: data from caPSURE. Manag Care Interface. 2005 Feb; 18(2):25-30. PMID: 15766061.
      View in: PubMed
    350. Li LC, Carroll P, Dahiya R. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst. 2005 Jan 19; 97(2):103-15. PMID: 15657340.
      View in: PubMed
    351. Breault JE, Shiina H, Igawa M, Ribeiro-Filho LA, Deguchi M, Enokida H, Urakami S, Terashima M, Nakagawa M, Kane CJ, Carroll P, Dahiya R. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):557-64. PMID: 15701841.
      View in: PubMed
    352. Kawakami T, Shiina H, Igawa M, Deguchi M, Nakajima K, Ogishima T, Tokizane T, Urakami S, Enokida H, Miura K, Ishii N, Kane CJ, Carroll P, Dahiya R. Inactivation of the hMSH3 mismatch repair gene in bladder cancer. Biochem Biophys Res Commun. 2004 Dec 17; 325(3):934-42. PMID: 15541380.
      View in: PubMed
    353. Zhao H, Li LC, Okino ST, Kane CJ, Carroll P, Dahiya R. Kidney gene database: a curated and integrated database of genes involved in kidney disease. J Urol. 2004 Dec; 172(6 Pt 1):2344-6. PMID: 15538263.
      View in: PubMed
    354. Master VA, Shinohara K, Carroll P. Ferromagnetic thermal ablation of locally recurrent prostate cancer: prostate specific antigen results and immediate/intermediate morbidities. J Urol. 2004 Dec; 172(6 Pt 1):2197-202. PMID: 15538231.
      View in: PubMed
    355. Jung JA, Coakley FV, Vigneron DB, Swanson MG, Qayyum A, Weinberg V, Jones KD, Carroll P, Kurhanewicz J. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology. 2004 Dec; 233(3):701-8. PMID: 15564406.
      View in: PubMed
    356. Speight JL, Elkin EP, Pasta DJ, Silva S, Lubeck DP, Carroll P, Litwin MS. Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1066-75. PMID: 15519776.
      View in: PubMed
    357. Carroll P, Chan JM, D'Amico AV, Gelmann EP, Iversen P, Klotz L, Nelson JB, Nelson PS, Nelson WG, Oh WK, Rosen N, Rubin MA, Sandler H, Sellers WR, Smith MR, Xu J, McMann MC, Kantoff PW. Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment. J Urol. 2004 Nov; 172(5 Pt 2):S3-5. PMID: 15535434.
      View in: PubMed
    358. Carroll P. The impact of patient advocacy: the University of California-San Francisco experience. J Urol. 2004 Nov; 172(5 Pt 2):S58-61; discussion S61-2. PMID: 15535445.
      View in: PubMed
    359. D'Amico AV, Moul J, Carroll P, Sun L, Lubeck D, Chen MH. Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy. J Urol. 2004 Nov; 172(5 Pt 2):S42-6; discussion S46-7. PMID: 15535442.
      View in: PubMed
    360. Chan JM, Jou RM, Carroll P. The relative impact and future burden of prostate cancer in the United States. J Urol. 2004 Nov; 172(5 Pt 2):S13-6; discussion S17. PMID: 15535436.
      View in: PubMed
    361. Arredondo SA, Downs TM, Lubeck DP, Pasta DJ, Silva SJ, Wallace KL, Carroll P. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol. 2004 Nov; 172(5 Pt 1):1830-4. PMID: 15540732.
      View in: PubMed
    362. Watson JE, Kamkar S, James K, Kowbel D, Andaya A, Paris PL, Simko J, Carroll P, McAlhany S, Rowley D, Collins C. Molecular analysis of WFDC1/ps20 gene in prostate cancer. Prostate. 2004 Oct 1; 61(2):192-9. PMID: 15305342.
      View in: PubMed
    363. Qayyum A, Coakley FV, Lu Y, Olpin JD, Wu L, Yeh BM, Carroll P, Kurhanewicz J. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol. 2004 Oct; 183(4):1079-83. PMID: 15385308.
      View in: PubMed
    364. Enokida H, Shiina H, Igawa M, Ogishima T, Kawakami T, Bassett WW, Anast JW, Li LC, Urakami S, Terashima M, Verma M, Kawahara M, Nakagawa M, Kane CJ, Carroll P, Dahiya R. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res. 2004 Sep 1; 64(17):5956-62. PMID: 15342374.
      View in: PubMed
    365. Cooperberg MR, Park S, Carroll P. Prostate cancer 2004: insights from national disease registries. Oncology (Williston Park). 2004 Sep; 18(10):1239-47; discussion 1248-50, 1256-8. PMID: 15526829.
      View in: PubMed
    366. Sasaki M, Nomoto M, Yonezawa S, Nakagawa M, Sakuragi N, Fujimoto S, Carroll P, Dahiya R. Distribution of a single nucleotide polymorphism on codon 211 of the androgen receptor gene and its correlation with human renal cell cancer in Japanese patients. Biochem Biophys Res Commun. 2004 Aug 20; 321(2):468-71. PMID: 15358199.
      View in: PubMed
    367. Li LC, Shiina H, Deguchi M, Zhao H, Okino ST, Kane CJ, Carroll P, Igawa M, Dahiya R. Age-dependent methylation of ESR1 gene in prostate cancer. Biochem Biophys Res Commun. 2004 Aug 20; 321(2):455-61. PMID: 15358197.
      View in: PubMed
    368. Cooperberg MR, Broering JM, Latini DM, Litwin MS, Wallace KL, Carroll P. Patterns of practice in the United States: insights from CaPSURE on prostate cancer management. Curr Urol Rep. 2004 Jun; 5(3):166-72. PMID: 15161564.
      View in: PubMed
    369. Greene KL, Meng MV, Elkin EP, Cooperberg MR, Pasta DJ, Kattan MW, Wallace K, Carroll P. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). J Urol. 2004 Jun; 171(6 Pt 1):2255-9. PMID: 15126797.
      View in: PubMed
    370. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll P. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol. 2004 Jun 1; 22(11):2141-9. PMID: 15169800; PMCID: PMC2997214.
    371. Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JE, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast TH, Vissers KJ, Schroder FH, Wildhagen MF, Febbo PG, Chinnaiyan AM, Pienta KJ, Carroll P, Rubin MA, Collins C, van Dekken H. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet. 2004 Jul 1; 13(13):1303-13. PMID: 15138198.
      View in: PubMed
    372. Moyad MA, Carroll P. Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention? Urol Clin North Am. 2004 May; 31(2):289-300. PMID: 15123408.
      View in: PubMed
    373. Moyad MA, Carroll P. Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention? Urol Clin North Am. 2004 May; 31(2):301-11. PMID: 15123409.
      View in: PubMed
    374. D'Amico AV, Moul JW, Carroll P, Cote K, Sun L, Lubeck D, Renshaw AA, Loffredo M, Chen MH. Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure. J Natl Cancer Inst. 2004 Apr 7; 96(7):509-15. PMID: 15069112.
      View in: PubMed
    375. Cooperberg MR, Downs TM, Carroll P. Radical retropubic prostatectomy frustrated by prior laparoscopic mesh herniorrhaphy. Surgery. 2004 Apr; 135(4):452-3; discussion 454. PMID: 15041971.
      View in: PubMed
    376. Strohmeyer DM, Berger AP, Moore DH, Bartsch G, Klocker H, Carroll P, Loening SA, Jensen RH. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis. Prostate. 2004 Apr 1; 59(1):43-58. PMID: 14991865.
      View in: PubMed
    377. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll P. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol. 2004 Apr; 171(4):1393-401. PMID: 15017184.
      View in: PubMed
    378. Yun EJ, Meng MV, Carroll P. Evaluation of the patient with hematuria. Med Clin North Am. 2004 Mar; 88(2):329-43. PMID: 15049581.
      View in: PubMed
    379. Master VA, Meng MV, Grossfeld GD, Koppie TM, Hirose R, Carroll P. Treatment and outcome of invasive bladder cancer in patients after renal transplantation. J Urol. 2004 Mar; 171(3):1085-8. PMID: 14767276.
      View in: PubMed
    380. Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Kattan MW, Carroll P, Litwin MS. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol. 2004 Feb; 171(2 Pt 1):703-7; discussion 707-8. PMID: 14713791.
      View in: PubMed
    381. Kane CJ, Mitchell JA, Meng MV, Anast J, Carroll P, Stoller ML. Laparoscopic partial nephrectomy with temporary arterial occlusion: description of technique and renal functional outcomes. Urology. 2004 Feb; 63(2):241-6. PMID: 14972462.
      View in: PubMed
    382. Mehta SS, Lubeck DP, Sadetsky N, Pasta DJ, Carroll P. Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE. J Urol. 2004 Jan; 171(1):215-9. PMID: 14665879.
      View in: PubMed
    383. Dhingsa R, Qayyum A, Coakley FV, Lu Y, Jones KD, Swanson MG, Carroll P, Hricak H, Kurhanewicz J. Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology. 2004 Jan; 230(1):215-20. PMID: 14695396.
      View in: PubMed
    384. Sasaki M, Kaneuchi M, Sakuragi N, Fujimoto S, Carroll P, Dahiya R. The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations. Biochem Biophys Res Commun. 2003 Dec 26; 312(4):1244-7. PMID: 14652007.
      View in: PubMed
    385. Cooperberg MR, Small EJ, D'Amico A, Carroll P. The evolving role of androgen deprivation therapy in the management of prostate cancer. Minerva Urol Nefrol. 2003 Dec; 55(4):219-38. PMID: 14765015.
      View in: PubMed
    386. Meng MV, Elkin EP, Harlan SR, Mehta SS, Lubeck DP, Carroll P. Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE. J Urol. 2003 Dec; 170(6 Pt 1):2279-83. PMID: 14634396.
      View in: PubMed
    387. Cooperberg MR, Lubeck DP, Mehta SS, Carroll P. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol. 2003 Dec; 170(6 Pt 2):S21-5; discussion S26-7. PMID: 14610406.
      View in: PubMed
    388. Kane CJ, Lubeck DP, Knight SJ, Spitalny M, Downs TM, Grossfeld GD, Pasta DJ, Mehta SS, Carroll P. Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE. Urology. 2003 Dec; 62(6):1035-9. PMID: 14665350.
      View in: PubMed
    389. Carroll P, Benaron DA, Blackledge G, Coakley FV, D'Amico AV, Higano CS, Iversen P, Kattan M, Nanus DM, Nelson JB, Oh WK, Roach M, Sellers WR, Smith MR, McMann MC, Kantoff PW. Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment. J Urol. 2003 Dec; 170(6 Pt 2):S3-5. PMID: 14610403.
      View in: PubMed
    390. Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll P, Lubeck DP. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE. J Urol. 2003 Nov; 170(5):1822-7. PMID: 14532784.
      View in: PubMed
    391. Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll P. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J Urol. 2003 Nov; 170(5):1804-7. PMID: 14532780.
      View in: PubMed
    392. Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll P, James JK, Hurd RE, Kurhanewicz J. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med. 2003 Nov; 50(5):944-54. PMID: 14587005.
      View in: PubMed
    393. D'Amico AV, Moul JW, Carroll P, Sun L, Lubeck D, Chen MH. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst. 2003 Sep 17; 95(18):1376-83. PMID: 13130113.
      View in: PubMed
    394. Staack A, Donjacour AA, Brody J, Cunha GR, Carroll P. Mouse urogenital development: a practical approach. Differentiation. 2003 Sep; 71(7):402-13. PMID: 12969333.
      View in: PubMed
    395. Cooperberg M, Lubeck DP, Penson D, Mehta SS, Carroll P, Kane CJ. Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE. J Urol. 2003 Sep; 170(3):905-8. PMID: 12913727.
      View in: PubMed
    396. Cooperberg MR, Master VA, Carroll P. Health related quality of life significance of single pad urinary incontinence following radical prostatectomy. J Urol. 2003 Aug; 170(2 Pt 1):512-5. PMID: 12853811.
      View in: PubMed
    397. Cooperberg MR, Grossfeld GD, Lubeck DP, Carroll P. National practice patterns and time trends in androgen ablation for localized prostate cancer. J Natl Cancer Inst. 2003 Jul 2; 95(13):981-9. PMID: 12837834; PMCID: PMC2994265.
    398. D'Amico AV, Moul J, Carroll P, Sun L, Lubeck D, Chen MH. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol. 2003 Jun 1; 21(11):2163-72. PMID: 12775742.
      View in: PubMed
    399. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 2003 Jun 1; 63(11):2872-80. PMID: 12782593.
      View in: PubMed
    400. Purohit RS, Shinohara K, Meng MV, Carroll P. Imaging clinically localized prostate cancer. Urol Clin North Am. 2003 May; 30(2):279-93. PMID: 12735504.
      View in: PubMed
    401. Patra SK, Patra A, Zhao H, Carroll P, Dahiya R. Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2. Biochem Biophys Res Commun. 2003 Mar 21; 302(4):759-66. PMID: 12646234.
      View in: PubMed
    402. Paris PL, Albertson DG, Alers JC, Andaya A, Carroll P, Fridlyand J, Jain AN, Kamkar S, Kowbel D, Krijtenburg PJ, Pinkel D, Schröder FH, Vissers KJ, Watson VJ, Wildhagen MF, Collins C, Van Dekken H. High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol. 2003 Mar; 162(3):763-70. PMID: 12598311; PMCID: PMC1868117.
    403. Staack A, Kassis AP, Olshen A, Wang Y, Wu D, Carroll P, Grossfeld GD, Cunha GR, Hayward SW. Quantitation of apoptotic activity following castration in human prostatic tissue in vivo. Prostate. 2003 Feb 15; 54(3):212-9. PMID: 12518326.
      View in: PubMed
    404. Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll P. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J Urol. 2003 Jan; 169(1):157-63. PMID: 12478126.
      View in: PubMed
    405. Litwin MS, Saigal CS, Lubeck DP, Li YP, Henning JM, Carroll P. Health-related quality of life in men with metastatic prostate cancer: the misleading effect of lead-time bias. BJU Int. 2003 Jan; 91(1):9-13. PMID: 12614241.
      View in: PubMed
    406. Cooperberg MR, Koppie TM, Lubeck DP, Ye J, Grossfeld GD, Mehta SS, Carroll P. How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE. Urology. 2003 Jan; 61(1):190-6. PMID: 12559294.
      View in: PubMed
    407. Grossfeld GD, Latini DM, Downs T, Lubeck DP, Mehta SS, Carroll P. Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy? J Urol. 2002 Dec; 168(6):2510-5. PMID: 12441951.
      View in: PubMed
    408. Powell IJ, Tangen CM, Miller GJ, Lowe BA, Haas G, Carroll P, Osswald MB, DeVERE WHITE R, Thompson IM, Crawford ED. Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109. J Urol. 2002 Nov; 168(5):2016-9. PMID: 12394698.
      View in: PubMed
    409. Katz D, Koppie TM, Wu D, Meng MV, Grossfeld GD, Sadesky N, Lubeck DP, Carroll P. Sociodemographic characteristics and health related quality of life in men attending prostate cancer support groups. J Urol. 2002 Nov; 168(5):2092-6. PMID: 12394716.
      View in: PubMed
    410. Grossfeld GD, Li YP, P Lubeck DP, Carroll P. Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy. Urology. 2002 Sep; 60(3 Suppl 1):57-62; discussion 62-3. PMID: 12231051.
      View in: PubMed
    411. Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll P. Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology. 2002 Sep; 60(3 Suppl 1):7-11; discussion 11-2. PMID: 12231037.
      View in: PubMed
    412. Carroll P, Kantoff PW, Balk SP, Brown MA, D'amico AV, George DJ, Grossfeld GD, Johnson CS, Kelly WK, Klotz L, Lee WR, Lubeck DP, Mcleod DG, Oh WK, Pollack A, Sartor O, Smith MR, Hart C. Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer. Urology. 2002 Sep; 60(3 Suppl 1):1-6. PMID: 12231036.
      View in: PubMed
    413. Lubeck DP, Grossfeld GD, Carroll P. A review of measurement of patient preferences for treatment outcomes after prostate cancer. Urology. 2002 Sep; 60(3 Suppl 1):72-7; discussion 77-8. PMID: 12231054.
      View in: PubMed
    414. Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll P. Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor. J Urol. 2002 Aug; 168(2):491-5. PMID: 12131295.
      View in: PubMed
    415. Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll P. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol. 2002 Aug; 168(2):530-5. PMID: 12131303.
      View in: PubMed
    416. Meng MV, Grossfeld GD, Carroll P, Small EJ. Neoadjuvant strategies for prostate cancer prior to radical prostatectomy. Semin Urol Oncol. 2002 Aug; 20(3 Suppl 1):10-8. PMID: 12198633.
      View in: PubMed
    417. Ribeiro-Filho LA, Franks J, Sasaki M, Shiina H, Li LC, Nojima D, Arap S, Carroll P, Enokida H, Nakagawa M, Yonezawa S, Dahiya R. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol Carcinog. 2002 Aug; 34(4):187-98. PMID: 12203370.
      View in: PubMed
    418. Elliott SP, Shinohara K, Logan SL, Carroll P. Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer. J Urol. 2002 Jul; 168(1):105-9. PMID: 12050501.
      View in: PubMed
    419. Litwin MS, Lubeck DP, Spitalny GM, Henning JM, Carroll P. Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. Cancer. 2002 Jul 1; 95(1):54-60. PMID: 12115317.
      View in: PubMed
    420. Master VA, Meng MV, Koppie TM, Carroll P, Grossfeld GD. Origin of urothelial carcinoma after renal transplant determined by fluorescence in situ hybridization. J Urol. 2002 Jun; 167(6):2521-2. PMID: 11992074.
      View in: PubMed
    421. Goharderakhshan RZ, Sudilovsky D, Carroll LA, Grossfeld GD, Marn R, Carroll P. Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy. Urology. 2002 May; 59(5):709-14. PMID: 11992845.
      View in: PubMed
    422. Penson DF, Grossfeld GD, Li YP, Henning JM, Lubeck DP, Carroll P. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor. J Urol. 2002 Apr; 167(4):1653-7; discussion 1657-8. PMID: 11912382.
      View in: PubMed
    423. Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, Carroll P, Hricak H. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology. 2002 Apr; 223(1):91-7. PMID: 11930052.
      View in: PubMed
    424. Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll P. Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology. 2002 Apr; 59(4):560-5. PMID: 11927314.
      View in: PubMed
    425. Downs TM, Kane CJ, Grossfeld GD, Meng MV, Carroll P. Surgery for prostate cancer: rationale, technique and outcomes. Cancer Metastasis Rev. 2002; 21(1):29-44. PMID: 12400995.
      View in: PubMed
    426. Grossfeld GD, Carroll P, Lindeman N, Meng M, Groshen S, Feng AC, Hawes D, Cote RJ. Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression. Urology. 2002 Jan; 59(1):97-102. PMID: 11796289.
      View in: PubMed
    427. Lubeck DP, Kim H, Grossfeld G, Ray P, Penson DF, Flanders SC, Carroll P. Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor. J Urol. 2001 Dec; 166(6):2281-5. PMID: 11696752.
      View in: PubMed
    428. Mitsiadis TA, Gayet O, Zhang N, Carroll P. Expression of Deltex1 during mouse embryogenesis: comparison with Notch1, 2 and 3 expression. Mech Dev. 2001 Dec; 109(2):399-403. PMID: 11731257.
      View in: PubMed
    429. Roach M, Kurhanewicz J, Carroll P. Spectroscopy in prostate cancer: hope or hype? Oncology (Williston Park). 2001 Nov; 15(11):1399-410; discussion 1415-6, 1418. PMID: 11758871.
      View in: PubMed
    430. Mueller-Lisse UG, Vigneron DB, Hricak H, Swanson MG, Carroll P, Bessette A, Scheidler J, Srivastava A, Males RG, Cha I, Kurhanewicz J. Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. Radiology. 2001 Nov; 221(2):380-90. PMID: 11687679.
      View in: PubMed
    431. Moul JW, Connelly RR, Lubeck DP, Bauer JJ, Sun L, Flanders SC, Grossfeld GD, Carroll P. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases. J Urol. 2001 Oct; 166(4):1322-7. PMID: 11547066.
      View in: PubMed
    432. Grossfeld GD, Carroll P. Orthotopic urinary diversion with the ileal neobladder. Tech Urol. 2001 Sep; 7(3):196-202. PMID: 11575516.
      View in: PubMed
    433. Grady B, Goharderakhshan R, Chang J, Ribeiro-Filho LA, Perinchery G, Franks J, Presti J, Carroll P, Dahiya R. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma. J Urol. 2001 Sep; 166(3):1088-92. PMID: 11490304.
      View in: PubMed
    434. Meng MV, Grossfeld GD, Williams GH, Dilworth S, Stoeber K, Mulley TW, Weinberg V, Carroll P, Tlsty TD. Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res. 2001 Sep; 7(9):2712-8. PMID: 11555583.
      View in: PubMed
    435. Li LC, Zhao H, Nakajima K, Oh BR, Ribeiro Filho LA, Carroll P, Dahiya R. Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J Urol. 2001 Aug; 166(2):705-9. PMID: 11458121.
      View in: PubMed
    436. Grossfeld GD, Small EJ, Lubeck DP, Latini D, Broering JM, Carroll P. Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy. Urology. 2001 Aug; 58(2 Suppl 1):56-64. PMID: 11502450.
      View in: PubMed
    437. Lubeck DP, Grossfeld GD, Carroll P. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer. Urology. 2001 Aug; 58(2 Suppl 1):94-100. PMID: 11502459.
      View in: PubMed
    438. Carroll P, Fair WR, Grossfeld GD, Heston WD, Lieberman R, Malkowicz SB, Stricker HJ, Sylvester J, Peehl DM, Meyer F, Hart C. Overview consensus statement. Urology. 2001 Aug; 58(2 Suppl 1):1-4. PMID: 11502434.
      View in: PubMed
    439. Grossfeld GD, Chaudhary UB, Reese DM, Carroll P, Small EJ. Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancer. Urology. 2001 Aug; 58(2):240-5. PMID: 11489710.
      View in: PubMed
    440. Mueller-Lisse UG, Swanson MG, Vigneron DB, Hricak H, Bessette A, Males RG, Wood PJ, Noworolski S, Nelson SJ, Barken I, Carroll P, Kurhanewicz J. Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging. Magn Reson Med. 2001 Jul; 46(1):49-57. PMID: 11443710.
      View in: PubMed
    441. Koppie TM, Grossfeld GD, Nudell DM, Weinberg VK, Carroll P. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy? J Urol. 2001 Jul; 166(1):111-5. PMID: 11435834.
      View in: PubMed
    442. Meng MV, Carroll P. Is it necessary to do staging pelvic lymph node dissection for T1c prostate cancer? Curr Urol Rep. 2001 Jun; 2(3):237-41. PMID: 12084271.
      View in: PubMed
    443. Park S, Shinohara K, Grossfeld GD, Carroll P. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 2001 May; 165(5):1409-14. PMID: 11342887.
      View in: PubMed
    444. Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll P. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology. 2001 Apr; 57(4):604-10. PMID: 11306357.
      View in: PubMed
    445. Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll P. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology. Urology. 2001 Apr; 57(4):599-603. PMID: 11306356.
      View in: PubMed
    446. Ornish DM, Lee KL, Fair WR, Pettengill EB, Carroll P. Dietary trial in prostate cancer: Early experience and implications for clinical trial design. Urology. 2001 Apr; 57(4 Suppl 1):200-1. PMID: 11295627.
      View in: PubMed
    447. Carroll P. Serum prostate-specific antigen for prostate cancer early detection: total, free, age- stratified, or complexed? Urology. 2001 Apr; 57(4):591-3. PMID: 11306354.
      View in: PubMed
    448. Grossfeld GD, Wolf JS, Litwan MS, Hricak H, Shuler CL, Agerter DC, Carroll P. Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. Am Fam Physician. 2001 Mar 15; 63(6):1145-54. PMID: 11277551.
      View in: PubMed
    449. Penson DF, Schonfeld WH, Flanders SC, Henke CJ, Warolin KL, Carroll P, Litwin MS. Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database. Urology. 2001 Mar; 57(3):499-503. PMID: 11248628.
      View in: PubMed
    450. Grossfeld GD, Chang JJ, Broering JM, Li YP, Lubeck DP, Flanders SC, Carroll P. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol. 2001 Mar; 165(3):851-6. PMID: 11176485.
      View in: PubMed
    451. Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up. Urology. 2001 Feb; 57(2):225-9. PMID: 11182325.
      View in: PubMed
    452. Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer. Urology. 2001 Feb; 57(2):217-24. PMID: 11182324.
      View in: PubMed
    453. Grossfeld GD, Carroll P. Prostate cancer early detection: a clinical perspective. Epidemiol Rev. 2001; 23(1):173-80. PMID: 11588845.
      View in: PubMed
    454. Carroll P. Rising PSA after a radical treatment. Eur Urol. 2001; 40 Suppl 2:9-16. PMID: 11684859.
      View in: PubMed
    455. Goharderakhshan RZ, Grossfeld GD, Kassis A, Shinohara K, Roach M, Carroll P. Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy. Urology. 2000 Oct 1; 56(4):622-6. PMID: 11018618.
      View in: PubMed
    456. Meng MV, Carroll P. When is pelvic lymph node dissection necessary before radical prostatectomy? A decision analysis. J Urol. 2000 Oct; 164(4):1235-40. PMID: 10992372.
      View in: PubMed
    457. Muscheck M, Abol-Enein H, Chew K, Moore D, Bhargava V, Ghoneim MA, Carroll P, Waldman FM. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization. Carcinogenesis. 2000 Sep; 21(9):1721-6. PMID: 10964104.
      View in: PubMed
    458. Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Carroll P. Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database. Urology. 2000 Sep 1; 56(3):430-5. PMID: 10962308.
      View in: PubMed
    459. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll P, Kurhanewicz J. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol. 2000 Aug; 164(2):400-4. PMID: 10893595.
      View in: PubMed
    460. Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, Lubeck D, Henning JM, Flanders SC, Carroll P. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor. J Urol. 2000 Jul; 164(1):81-8. PMID: 10840429.
      View in: PubMed
    461. Grossfeld GD, Tigrani VS, Nudell D, Roach M, Weinberg VK, Presti JC, Small EJ, Carroll P. Management of a positive surgical margin after radical prostatectomy: decision analysis. J Urol. 2000 Jul; 164(1):93-9; discussion 100. PMID: 10840431.
      View in: PubMed
    462. Roach M, Chen A, Song J, Diaz A, Presti J, Carroll P. Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancer. Semin Urol Oncol. 2000 May; 18(2):108-14. PMID: 10875450.
      View in: PubMed
    463. Oh BR, Sasaki M, Perinchery G, Ryu SB, Park YI, Carroll P, Dahiya R. Frequent genotype changes at -308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer. J Urol. 2000 May; 163(5):1584-7. PMID: 10751892.
      View in: PubMed
    464. Perinchery G, Sasaki M, Angan A, Kumar V, Carroll P, Dahiya R. Deletion of Y-chromosome specific genes in human prostate cancer. J Urol. 2000 Apr; 163(4):1339-42. PMID: 10737540.
      View in: PubMed
    465. Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Henning JM, Stier DM, Carroll P. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. J Urol. 2000 Apr; 163(4):1171-7; quiz 1295. PMID: 10737489.
      View in: PubMed
    466. Carroll P. Prostate biopsy: a wealth of information when done and interpreted correctly. J Clin Oncol. 2000 Mar; 18(6):1161-3. PMID: 10715283.
      View in: PubMed
    467. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P, Dahiya R. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 2000 Feb 15; 60(4):873-6. PMID: 10706097.
      View in: PubMed
    468. Nudell DM, Wefer AE, Hricak H, Carroll P. Imaging for recurrent prostate cancer. Radiol Clin North Am. 2000 Jan; 38(1):213-29. PMID: 10664674.
      View in: PubMed
    469. Roach M, Reese D, Weinberg V, Small EJ, Carroll P. Is the use of anti-androgen monotherapy appropriate in patients with advanced prostate cancer? J Clin Oncol. 2000 Jan; 18(2):448-50. PMID: 10637263.
      View in: PubMed
    470. Lubeck DP, Litwin MS, Henning JM, Mathias SD, Bloor L, Carroll P. An instrument to measure patient satisfaction with healthcare in an observational database: results of a validation study using data from CaPSURE. Am J Manag Care. 2000 Jan; 6(1):70-6. PMID: 11009748.
      View in: PubMed
    471. Tigrani VS, Reese DM, Small EJ, Presti JC, Carroll P. Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis. Urology. 2000 Jan; 55(1):36-40. PMID: 10654891.
      View in: PubMed
    472. Nudell DM, Grossfeld GD, Weinberg VK, Roach M, Carroll P. Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns. Urology. 1999 Dec; 54(6):1049-57. PMID: 10604707.
      View in: PubMed
    473. Yu KK, Scheidler J, Hricak H, Vigneron DB, Zaloudek CJ, Males RG, Nelson SJ, Carroll P, Kurhanewicz J. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology. 1999 Nov; 213(2):481-8. PMID: 10551230.
      View in: PubMed
    474. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll P, Kurhanewicz J. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. Radiology. 1999 Nov; 213(2):473-80. PMID: 10551229.
      View in: PubMed
    475. Overstreet JW, Fuh VL, Gould J, Howards SS, Lieber MM, Hellstrom W, Shapiro S, Carroll P, Corfman RS, Petrou S, Lewis R, Toth P, Shown T, Roy J, Jarow JP, Bonilla J, Jacobsen CA, Wang DZ, Kaufman KD. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol. 1999 Oct; 162(4):1295-300. PMID: 10492183.
      View in: PubMed
    476. Olumi AF, Grossfeld GD, Hayward SW, Carroll P, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999 Oct 1; 59(19):5002-11. PMID: 10519415.
      View in: PubMed
    477. Koppie TM, Shinohara K, Grossfeld GD, Presti JC, Carroll P. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. J Urol. 1999 Aug; 162(2):427-32. PMID: 10411051.
      View in: PubMed
    478. Morey AF, McAninch JW, Tiller BK, Duckett CP, Carroll P. Single shot intraoperative excretory urography for the immediate evaluation of renal trauma. J Urol. 1999 Apr; 161(4):1088-92. PMID: 10081844.
      View in: PubMed
    479. Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC, Carroll P. Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology. 1999 Jan; 53(1):180-6. PMID: 9886609.
      View in: PubMed
    480. Grossfeld GD, Muscheck M, Stein JP, Chew K, Cote RJ, Ginsberg DA, Waldman FM, Carroll P. Cellular proliferation and cell-cell cycle regulatory proteins as prognostic markers for transitional cell carcinoma of the bladder. Adv Exp Med Biol. 1999; 462:425-35. PMID: 10599445.
      View in: PubMed
    481. Kindrick AV, Grossfeld GD, Stier DM, Flanders SC, Henning JM, Carroll P. Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database. J Urol. 1998 Dec; 160(6 Pt 1):2102-6. PMID: 9817332.
      View in: PubMed
    482. Rogers R, Grossfeld GD, Roach M, Shinohara K, Presti JC, Carroll P. Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. J Urol. 1998 Nov; 160(5):1748-53. PMID: 9783945.
      View in: PubMed
    483. Grossfeld GD, Carroll P. Evaluation of asymptomatic microscopic hematuria. Urol Clin North Am. 1998 Nov; 25(4):661-76. PMID: 10026773.
      View in: PubMed
    484. Grossfeld GD, Stier DM, Flanders SC, Henning JM, Schonfeld W, Warolin K, Carroll P. Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database. J Urol. 1998 Oct; 160(4):1398-404. PMID: 9751363.
      View in: PubMed
    485. Yu KK, Hricak H, Grossfeld GD, Carroll P. Prediction of patient outcome after radical prostatectomy by imaging: choice of outcome measure. Acad Radiol. 1998 Sep; 5 Suppl 2:S347-8. PMID: 9750850.
      View in: PubMed
    486. Hovey RM, Chu L, Balazs M, DeVries S, Moore D, Sauter G, Carroll P, Waldman FM. Genetic alterations in primary bladder cancers and their metastases. Cancer Res. 1998 Aug 15; 58(16):3555-60. PMID: 9721860.
      View in: PubMed
    487. Turek PJ, Lowther DN, Carroll P. Fertility issues and their management in men with testis cancer. Urol Clin North Am. 1998 Aug; 25(3):517-31. PMID: 9728221.
      View in: PubMed
    488. Litwin MS, Pasta DJ, Stoddard ML, Henning JM, Carroll P. Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993. J Urol. 1998 Aug; 160(2):445-8. PMID: 9679895.
      View in: PubMed
    489. Mueller P, Carroll P, Bowers E, Moore D, Cher M, Presti J, Wessman M, Pallavicini MG. Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant. Cancer. 1998 Aug 1; 83(3):538-46. PMID: 9690547.
      View in: PubMed
    490. McCune JM, Loftus R, Schmidt DK, Carroll P, Webster D, Swor-Yim LB, Francis IR, Gross BH, Grant RM. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest. 1998 Jun 1; 101(11):2301-8. PMID: 9616201; PMCID: PMC508819.
    491. Litwin MS, Lubeck DP, Henning JM, Carroll P. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. J Urol. 1998 Jun; 159(6):1988-92. PMID: 9598504.
      View in: PubMed
    492. Serra AD, Hricak H, Coakley FV, Kim B, Dudley A, Morey A, Tschumper B, Carroll P. Inconclusive clinical and ultrasound evaluation of the scrotum: impact of magnetic resonance imaging on patient management and cost. Urology. 1998 Jun; 51(6):1018-21. PMID: 9609643.
      View in: PubMed
    493. Grossfeld GD, Olumi AF, Connolly JA, Chew K, Gibney J, Bhargava V, Waldman FM, Carroll P. Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity. J Urol. 1998 May; 159(5):1437-43. PMID: 9554329.
      View in: PubMed
    494. Dahiya R, Deng G, Selph C, Carroll P, Presti J. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer. Biochem Mol Biol Int. 1998 Feb; 44(2):407-15. PMID: 9530523.
      View in: PubMed
    495. Sarosdy MF, Manyak MJ, Sagalowsky AI, Belldegrun A, Benson MC, Bihrle W, Carroll P, Ellis WJ, Hudson MA, Sharkey FE. Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guérin. Urology. 1998 Feb; 51(2):226-31. PMID: 9495702.
      View in: PubMed
    496. Grossfeld GD, Small EJ, Carroll P. Intermittent androgen deprivation for clinically localized prostate cancer: initial experience. Urology. 1998 Jan; 51(1):137-44. PMID: 9457309.
      View in: PubMed
    497. Aboseif SR, Borirakchanyavat S, Lue TF, Carroll P. Continence mechanism of the ileal neobladder in women: a urodynamics study. World J Urol. 1998; 16(6):400-4. PMID: 9870288.
      View in: PubMed
    498. Aboseif S, Shinohara K, Borirakchanyavat S, Deirmenjian J, Carroll P. The effect of cryosurgical ablation of the prostate on erectile function. Br J Urol. 1997 Dec; 80(6):918-22. PMID: 9439410.
      View in: PubMed
    499. Shinohara K, Rhee B, Presti JC, Carroll P. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol. 1997 Dec; 158(6):2206-9; discussion 2209-10. PMID: 9366345.
      View in: PubMed
    500. Connolly JA, Shinohara K, Carroll P. Cryosurgery for locally advanced (T3) prostate cancer. Semin Urol Oncol. 1997 Nov; 15(4):244-9. PMID: 9421452.
      View in: PubMed
    501. Borirakchanyavat S, Aboseif SR, Carroll P, Tanagho EA, Lue TF. Continence mechanism of the isolated female urethra: an anatomical study of the intrapelvic somatic nerves. J Urol. 1997 Sep; 158(3 Pt 1):822-6. PMID: 9258091.
      View in: PubMed
    502. Borirakchanyavat S, Bhargava V, Shinohara K, Toke A, Carroll P, Presti JC. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy. Urology. 1997 Sep; 50(3):373-8. PMID: 9301700.
      View in: PubMed
    503. Connolly JA, Presti JC, Cher ML, Chew K, Shinohara K, Carroll P. Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy. J Urol. 1997 Aug; 158(2):515-8. PMID: 9224336.
      View in: PubMed
    504. Dahiya R, McCarville J, Lee C, Hu W, Kaur G, Carroll P, Deng G. Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer. Int J Cancer. 1997 Jul 17; 72(2):283-8. PMID: 9219834.
      View in: PubMed
    505. Lubeck DP, Litwin MS, Henning JM, Carroll P. Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database. Qual Life Res. 1997 Jul; 6(5):385-92. PMID: 9290305.
      View in: PubMed
    506. Balázs M, Carroll P, Kerschmann R, Sauter G, Waldman FM. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization. Genes Chromosomes Cancer. 1997 Jun; 19(2):84-9. PMID: 9171998.
      View in: PubMed
    507. Bander NH, Carroll P, Russo P. Summary of immunohistologic dissection of the human kidney using monoclonal antibodies (by Neil H. Bander, MD, Carlos Cordon-Cardo, MD, PhD, Connie L. Finstad, PhD, Willet F. Whitmore, Jr, MD, E. Darracott Vaughan, Jr, MD, Herbert F. Oettgen, MD, Myron Melamed, MD, and Lloyd J. Old, MD). 1985. Semin Urol Oncol. 1997 May; 15(2):123-9. PMID: 9134607.
      View in: PubMed
    508. Connolly JA, Shinohara K, Presti JC, Carroll P. Prostate-specific antigen after cryosurgical ablation of the prostate. Defining the appropriate response. Urol Clin North Am. 1997 May; 24(2):415-20. PMID: 9126239.
      View in: PubMed
    509. Gordon W, Siegmund K, Stanisic TH, McKnight B, Harris IT, Carroll P, Paradelo JC, Meyers FJ, Chapman RA, Meyskens FL. A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group. Int J Radiat Oncol Biol Phys. 1997 Apr 1; 38(1):83-94. PMID: 9212008.
      View in: PubMed
    510. Narumi Y, Hricak H, Presti JC, Forstner R, Sica GT, Kuroda C, Sawai Y, Kotake T, Kinouchi T, Carroll P. MR imaging evaluation of renal cell carcinoma. Abdom Imaging. 1997 Mar-Apr; 22(2):216-25. PMID: 9013538.
      View in: PubMed
    511. Carroll P, Presti JC, Small E, Roach M. Focal therapy for prostate cancer 1996: maximizing outcome. Urology. 1997 Mar; 49(3A Suppl):84-94. PMID: 9123742.
      View in: PubMed
    512. Presti JC, Hovey R, Bhargava V, Carroll P, Shinohara K. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations. J Urol. 1997 Mar; 157(3):907-11; discussion 911-2. PMID: 9072597.
      View in: PubMed
    513. Stoller ML, Gentle DL, McDonald MW, Reese JH, Tacker JR, Carroll P, Best C. Endoscopic management of upper tract urothelial tumors. Tech Urol. 1997; 3(3):152-7. PMID: 9422447.
      View in: PubMed
    514. Friedman GD, Carroll P, Cattolica EV, Hiatt RA. Can hematuria be a predictor as well as a symptom or sign of bladder cancer? Cancer Epidemiol Biomarkers Prev. 1996 Dec; 5(12):993-6. PMID: 8959322.
      View in: PubMed
    515. Presti JC, Hricak H, Shinohara K, Carroll P. Prediction of focal extracapsular extension at radical prostatectomy: Relative merit of transrectal ultrasound, endorectal magnetic resonance imaging, prostate specific antigen, prostate specific antigen density, and systematic biopsy. Urol Oncol. 1996 Nov-Dec; 2(6):177-83. PMID: 21224166.
      View in: PubMed
    516. Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R, Carroll P. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1996 Nov; 48(5):773-7. PMID: 8911524.
      View in: PubMed
    517. Connolly JA, Shinohara K, Presti JC, Carroll P. Should cryosurgery be considered a therapeutic option in localized prostate cancer? Urol Clin North Am. 1996 Nov; 23(4):623-31. PMID: 8948416.
      View in: PubMed
    518. Presti JC, Hovey R, Carroll P, Shinohara K. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate. J Urol. 1996 Nov; 156(5):1685-90. PMID: 8863571.
      View in: PubMed
    519. Small EJ, Fippin LJ, Ernest ML, Carroll P. A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium. Cancer. 1996 Oct 15; 78(8):1775-80. PMID: 8859191.
      View in: PubMed
    520. Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll P. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology. 1996 Oct; 48(4):594-9. PMID: 8886066.
      View in: PubMed
    521. Seltzer MA, Shinohara K, Bhargava V, Carroll P, Presti JC. Comparison of systematic sextant and lesion directed biopsies in prostate cancer detection. Urol Oncol. 1996 Sep-Oct; 2(5):136-8. PMID: 21224157.
      View in: PubMed
    522. Kurhanewicz J, Vigneron DB, Hricak H, Parivar F, Nelson SJ, Shinohara K, Carroll P. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology. 1996 Aug; 200(2):489-96. PMID: 8685346.
      View in: PubMed
    523. Presti JC, Carroll P. Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate. Semin Urol Oncol. 1996 Aug; 14(3):134-8. PMID: 8865474.
      View in: PubMed
    524. Sarosdy MF, Pisters LL, Carroll P, Benson MC, Moon TD, Lamm DL, Hudson MA, Lerner SP, Koch MO, Schellhammer PF. Bropirimine immunotherapy of upper urinary tract carcinoma in situ. Urology. 1996 Jul; 48(1):28-32. PMID: 8693647.
      View in: PubMed
    525. Cher ML, Bova GS, Moore DH, Small EJ, Carroll P, Pin SS, Epstein JI, Isaacs WB, Jensen RH. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res. 1996 Jul 1; 56(13):3091-102. PMID: 8674067.
      View in: PubMed
    526. Shinohara K, Connolly JA, Presti JC, Carroll P. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol. 1996 Jul; 156(1):115-20; discussion 120-1. PMID: 8648771.
      View in: PubMed
    527. Chen M, Hricak H, Kalbhen CL, Kurhanewicz J, Vigneron DB, Weiss JM, Carroll P. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. AJR Am J Roentgenol. 1996 May; 166(5):1157-63. PMID: 8615261.
      View in: PubMed
    528. Cher ML, Stephenson RA, James BC, Carroll P. Cellular proliferative fraction of metastatic lymph nodes predicts survival in stage D1 (TxN+M0) prostate cancer. J Urol. 1996 May; 155(5):1674-7. PMID: 8627851.
      View in: PubMed
    529. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology. 1996 Mar; 198(3):795-805. PMID: 8628874.
      View in: PubMed
    530. Kalbhen CL, Hricak H, Shinohara K, Chen M, Parivar F, Kurhanewicz J, Vigneron DB, Carroll P. Prostate carcinoma: MR imaging findings after cryosurgery. Radiology. 1996 Mar; 198(3):807-11. PMID: 8628875.
      View in: PubMed
    531. Connolly JA, Shinohara K, Presti JC, Carroll P. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology. 1996 Feb; 47(2):225-31. PMID: 8607239.
      View in: PubMed
    532. Presti JC, Hricak H, Narayan PA, Shinohara K, White S, Carroll P. Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR Am J Roentgenol. 1996 Jan; 166(1):103-8. PMID: 8571856.
      View in: PubMed
    533. Lue TF, Gleason CA, Brock GB, Carroll P, Tanagho EA. Intraoperative electrostimulation of the cavernous nerve: technique, results and limitations. J Urol. 1995 Oct; 154(4):1426-8. PMID: 7658549.
      View in: PubMed
    534. Aboseif S, Shinohara K, Weidner N, Narayan P, Carroll P. The significance of prostatic intra-epithelial neoplasia. Br J Urol. 1995 Sep; 76(3):355-9. PMID: 7551846.
      View in: PubMed
    535. Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM, Carroll P. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol. 1995 Jul; 154(1):69-71. PMID: 7539869.
      View in: PubMed
    536. Connolly JA, Presti JC, Carroll P. Anterior bladder neck tube reconstruction at radical prostatectomy preserves functional urethral length--a comparative urodynamic study. Br J Urol. 1995 Jun; 75(6):766-70. PMID: 7613835.
      View in: PubMed
    537. Wolf JS, Carroll P, Stoller ML. Cost-effectiveness v patient preference in the choice of treatment for distal ureteral calculi: a literature-based decision analysis. J Endourol. 1995 Jun; 9(3):243-8. PMID: 7550267.
      View in: PubMed
    538. Cher ML, Shinohara K, Breslin S, Vapnek J, Carroll P. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer. Br J Urol. 1995 Jun; 75(6):771-7. PMID: 7542137.
      View in: PubMed
    539. White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, Weiss JM, Narayan P, Carroll P. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology. 1995 May; 195(2):385-90. PMID: 7724756.
      View in: PubMed
    540. Sauter G, Carroll P, Moch H, Kallioniemi A, Kerschmann R, Narayan P, Mihatsch MJ, Waldman FM. c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am J Pathol. 1995 May; 146(5):1131-9. PMID: 7747807; PMCID: PMC1869279.
    541. Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch MJ, Waldman FM. Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer. Int J Cancer. 1995 Apr 21; 64(2):99-103. PMID: 7615360.
      View in: PubMed
    542. Marks LB, Carroll P, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995 Mar 30; 31(5):1257-80. PMID: 7713787.
      View in: PubMed
    543. Cher ML, Carroll P. Screening for prostate cancer. West J Med. 1995 Mar; 162(3):235-42. PMID: 7536993; PMCID: PMC1022708.
    544. Wolf JS, Cher M, Dall'era M, Presti JC, Hricak H, Carroll P. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol. 1995 Mar; 153(3 Pt 2):993-9. PMID: 7853590.
      View in: PubMed
    545. Nguyen HT, Carroll P. Blunt renal trauma: renal preservation through careful staging and selective surgery. Semin Urol. 1995 Feb; 13(1):83-9. PMID: 7597358.
      View in: PubMed
    546. Cher ML, Chew K, Rosenau W, Carroll P. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression. Prostate. 1995 Feb; 26(2):87-93. PMID: 7855002.
      View in: PubMed
    547. Cher ML, Ito T, Weidner N, Carroll P, Jensen RH. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol. 1995 Jan; 153(1):249-54. PMID: 7966782.
      View in: PubMed
    548. Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, Weiss J, Narayan P, Carroll P. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. Radiology. 1994 Dec; 193(3):703-9. PMID: 7972810.
      View in: PubMed
    549. Phan CN, Wilkinson M, Cohen MB, Dunn S, Carroll P. Primary osteogenic sarcoma of the urinary bladder successfully treated with combination therapy. Urology. 1994 Nov; 44(5):771-4. PMID: 7974956.
      View in: PubMed
    550. Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll P, Hricak H. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology. 1994 Oct; 193(1):239-45. PMID: 8090898.
      View in: PubMed
    551. Wolf JS, Brock GB, Gleason CA, Zvara P, Lue TF, Carroll P. Laparoscopically implantable nerve-stimulating electrode (LINSE): application to the cavernous nerve in acute and chronic canine models. J Endourol. 1994 Oct; 8(5):375-8. PMID: 7858627.
      View in: PubMed
    552. Chen BJ, Carroll P, Samson L. The Escherichia coli AlkB protein protects human cells against alkylation-induced toxicity. J Bacteriol. 1994 Oct; 176(20):6255-61. PMID: 7928996; PMCID: PMC196966.
    553. Diaz A, Roach M, Marquez C, Coleman L, Pickett B, Wolfe JS, Carroll P, Narayan P. Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):323-9. PMID: 7523343.
      View in: PubMed
    554. Shinohara K, Wolf JS, Narayan P, Carroll P. Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications. J Urol. 1994 Jul; 152(1):120-3. PMID: 7515447.
      View in: PubMed
    555. Small EJ, Frye JW, Wilkinson MJ, Carroll P, Ernest ML, Stagg RJ. A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma. Cancer. 1994 Jun 1; 73(11):2803-7. PMID: 8194022.
      View in: PubMed
    556. Carroll P. Laparoscopic urological surgery: differentiating what should be done from what can be done. J Urol. 1994 Jun; 151(6):1603-4. PMID: 8189573.
      View in: PubMed
    557. Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ, Waldman F. Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer. 1994 May 15; 57(4):508-14. PMID: 8181854.
      View in: PubMed
    558. Carroll P, McAninch JW, Wong A, Wolf JS, Newton C. Outcome after temporary vascular occlusion for the management of renal trauma. J Urol. 1994 May; 151(5):1171-3. PMID: 8158752.
      View in: PubMed
    559. Narayan P, Lowe BA, Carroll P, Thompson IM. Neoadjuvant hormonal therapy and radical prostatectomy for clinical stage C carcinoma of the prostate. Br J Urol. 1994 May; 73(5):544-8. PMID: 8012777.
      View in: PubMed
    560. Sauter G, Deng G, Moch H, Kerschmann R, Matsumura K, De Vries S, George T, Fuentes J, Carroll P, Mihatsch MJ. Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. Am J Pathol. 1994 Apr; 144(4):756-66. PMID: 8160775; PMCID: PMC1887234.
    561. Carroll P. Watchful waiting for localized prostate cancer. West J Med. 1994 Mar; 160(3):249. PMID: 8191759; PMCID: PMC1022391.
    562. Cher ML, Carroll P. Screening for prostate cancer. West J Med. 1994 Mar; 160(3):250. PMID: 7514824; PMCID: PMC1022392.
    563. Small EJ, Carroll P. Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome. Urology. 1994 Mar; 43(3):408-10. PMID: 7510915.
      View in: PubMed
    564. Vapnek JM, Hricak H, Shinohara K, Popovich M, Carroll P. Staging accuracy of magnetic resonance imaging versus transrectal ultrasound in stages A and B prostatic cancer. Urol Int. 1994; 53(4):191-5. PMID: 7855937.
      View in: PubMed
    565. Wolf JS, Aronson FR, Small EJ, Carroll P. Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimens. J Surg Oncol. 1994 Jan; 55(1):7-13. PMID: 8289458.
      View in: PubMed
    566. Roach M, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, Navvab Z, Carroll P. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1994 Jan 1; 28(1):33-7. PMID: 7505775.
      View in: PubMed
    567. Gómez RG, McAninch JW, Carroll P. Adrenal gland trauma: diagnosis and management. J Trauma. 1993 Dec; 35(6):870-4. PMID: 8263985.
      View in: PubMed
    568. Wolf JS, Shinohara K, Kerlikowske KM, Narayan P, Stoller ML, Carroll P. Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis. Urology. 1993 Dec; 42(6):680-8. PMID: 8256401.
      View in: PubMed
    569. Stoller ML, Irby PB, Osman M, Carroll P. Laparoscopic marsupialization of a simple renal cyst. J Urol. 1993 Nov; 150(5 Pt 1):1486-8. PMID: 8411433.
      View in: PubMed
    570. Ingerman A, Broderick G, Williams RD, Carroll P. Negative repeat transurethral resection of prostate fails to identify patients with stage A1 prostatic carcinoma at lower risk of progression: a long-term study. Urology. 1993 Nov; 42(5):528-32. PMID: 8236594.
      View in: PubMed
    571. Carroll P, Sendtner M, Meyer M, Thoenen H. Rat ciliary neurotrophic factor (CNTF): gene structure and regulation of mRNA levels in glial cell cultures. Glia. 1993 Nov; 9(3):176-87. PMID: 8294148.
      View in: PubMed
    572. Abu-Elmagd K, Van Thiel DH, Jegasothy BV, Jacobs JC, Carroll P, Rodriquez-Rilo H, Ackerman CD, Fung JJ, Starzl TE. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). Ann Intern Med. 1993 Oct 1; 119(7 Pt 1):595-8. PMID: 7689802; PMCID: PMC3091479.
    573. Wolf JS, Shinohara K, Carroll P, Narayan P. Combined role of transrectal ultrasonography, Gleason score, and prostate-specific antigen in predicting organ-confined prostate cancer. Urology. 1993 Aug; 42(2):131-7. PMID: 7690168.
      View in: PubMed
    574. Odocha O, McCauley J, Scantlebury V, Shapiro R, Carroll P, Jordan M, Vivas C, Fung JJ, Starzl TE. Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug; 25(4):2433-4. PMID: 7689268; PMCID: PMC2981169.
    575. Weidner N, Carroll P, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993 Aug; 143(2):401-9. PMID: 7688183; PMCID: PMC1887042.
    576. McAninch JW, Carroll P, Armenakas NA, Lee P. Renal gunshot wounds: methods of salvage and reconstruction. J Trauma. 1993 Aug; 35(2):279-83; discussion 283-4. PMID: 8355309.
      View in: PubMed
    577. Odocha O, McCauley J, Scantlebury V, Shapiro R, Carroll P, Jordan M, Vivas C, Fung JJ, Starzl TE. Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug; 25(4):2435. PMID: 7689269; PMCID: PMC2978522.
    578. Cohen MB, Waldman FM, Carroll P, Kerschmann R, Chew K, Mayall BH. Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder. Hum Pathol. 1993 Jul; 24(7):772-8. PMID: 8100555.
      View in: PubMed
    579. Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll P, Ernest ML, Stagg RJ. A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma. Cancer. 1993 Jun 1; 71(11):3601-4. PMID: 8490909.
      View in: PubMed
    580. Sauter G, Moch H, Moore D, Carroll P, Kerschmann R, Chew K, Mihatsch MJ, Gudat F, Waldman F. Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res. 1993 May 15; 53(10 Suppl):2199-203. PMID: 8097962.
      View in: PubMed
    581. Foster LS, Jajodia P, Fournier G, Shinohara K, Carroll P, Narayan P. The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. J Urol. 1993 May; 149(5):1024-8. PMID: 7683341.
      View in: PubMed
    582. Presti JC, Herr HW, Carroll P. Fertility and testis cancer. Urol Clin North Am. 1993 Feb; 20(1):173-9. PMID: 8434435.
      View in: PubMed
    583. Carroll P, Waldman FM, Rosenau W, Cohen MB, Vapnek JM, Fong P, Narayan P, Mayall BH. Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression. J Urol. 1993 Feb; 149(2):403-7. PMID: 8093910.
      View in: PubMed
    584. Waldman FM, Carroll P, Cohen MB, Kerschmann R, Chew K, Mayall BH. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder. Mod Pathol. 1993 Jan; 6(1):20-4. PMID: 8093979.
      View in: PubMed
    585. Gasparini ME, Hinman F, Presti JC, Schmidt RA, Carroll P. Continence after radical cystoprostatectomy and total bladder replacement: a urodynamic analysis. J Urol. 1992 Dec; 148(6):1861-4. PMID: 1433621.
      View in: PubMed
    586. Hricak H, Carroll P. Determination of prostate volume with transrectal ultrasound for cancer screening. Part I. Comparison with prostate specific antigen assays. Invest Radiol. 1992 Sep; 27(9):751-3. PMID: 1383174.
      View in: PubMed
    587. Carroll P, Presti JC. Comparison of plicated and stapled continent ileocecal stoma. Urology. 1992 Aug; 40(2):107-9. PMID: 1502742.
      View in: PubMed
    588. Vapnek JM, Hricak H, Carroll P. Recent advances in imaging studies for staging of penile and urethral carcinoma. Urol Clin North Am. 1992 May; 19(2):257-66. PMID: 1574816.
      View in: PubMed
    589. Carroll P, Dixon CM. Surgical anatomy of the male and female urethra. Urol Clin North Am. 1992 May; 19(2):339-46. PMID: 1574824.
      View in: PubMed
    590. Carroll P, Sugimura K, Cohen MB, Hricak H. Detection and staging of prostatic carcinoma after transurethral resection or open enucleation of the prostate: accuracy of magnetic resonance imaging. J Urol. 1992 Feb; 147(2):402-6. PMID: 1370698.
      View in: PubMed
    591. Myneni L, Hricak H, Carroll P. Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances. Br J Urol. 1991 Dec; 68(6):571-8. PMID: 1773285.
      View in: PubMed
    592. Wolf JS, Carroll P. Bilateral renal oncocytomas: management and nuclear analysis. J Surg Oncol. 1991 Dec; 48(4):272-6. PMID: 1745053.
      View in: PubMed
    593. Gasparini M, Carroll P, Stoller M. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction. Urology. 1991 Nov; 38(5):408-12. PMID: 1719688.
      View in: PubMed
    594. Presti JC, Carroll P. Bilateral spontaneous renal hemorrhage due to polyarteritis nodosa. West J Med. 1991 Nov; 155(5):527-8. PMID: 1687716; PMCID: PMC1003079.
    595. Vapnek JM, Quivey JM, Carroll P. Acquired immunodeficiency syndrome-related Kaposi's sarcoma of the male genitalia: management with radiation therapy. J Urol. 1991 Aug; 146(2):333-6. PMID: 1856928.
      View in: PubMed
    596. Waldman FM, Carroll P, Kerschmann R, Cohen MB, Field FG, Mayall BH. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res. 1991 Jul 15; 51(14):3807-13. PMID: 1676611.
      View in: PubMed
    597. McAninch JW, Carroll P, Klosterman PW, Dixon CM, Greenblatt MN. Renal reconstruction after injury. J Urol. 1991 May; 145(5):932-7. PMID: 2016804.
      View in: PubMed
    598. Semelka RC, Hricak H, Stevens SK, Finegold R, Tomei E, Carroll P. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses. Radiology. 1991 Mar; 178(3):803-9. PMID: 1994422.
      View in: PubMed
    599. Carroll P, McAninch JW. Use of the ileocecal segment for bladder substitution or continent urinary diversion. Urol Int. 1991; 46(3):283-9. PMID: 1926643.
      View in: PubMed
    600. McAninch JW, Dixon CM, Carroll P. [The surgical treatment of renal trauma]. Vestn Khir Im I I Grek. 1990 Nov; 145(11):64-72. PMID: 1966179.
      View in: PubMed
    601. Wilkinson M, Carroll P. Testicular carcinoma in patients positive and at risk for human immunodeficiency virus. J Urol. 1990 Nov; 144(5):1157-9. PMID: 2231890.
      View in: PubMed
    602. Baskin LS, Dixon C, Stoller ML, Carroll P. Pyoderma gangrenosum presenting as Fournier's gangrene. J Urol. 1990 Oct; 144(4):984-6. PMID: 2398576.
      View in: PubMed
    603. Carroll P, McAninch JW, Klosterman P, Greenblatt M. Renovascular trauma: risk assessment, surgical management, and outcome. J Trauma. 1990 May; 30(5):547-52; discussion 553-4. PMID: 2342137.
      View in: PubMed
    604. Presti JC, Schmidt RA, Narayan PA, Carroll P, Tanagho EA. Pathophysiology of urinary incontinence after radical prostatectomy. J Urol. 1990 May; 143(5):975-8. PMID: 2329614.
      View in: PubMed
    605. Baskin LS, Carroll P, Cattolica EV, McAninch JW. Necrotising soft tissue infections of the perineum and genitalia. Bacteriology, treatment and risk assessment. Br J Urol. 1990 May; 65(5):524-9. PMID: 2354320.
      View in: PubMed
    606. Carroll P, Presti JC, McAninch JW, Tanagho EA. Functional characteristics of the continent ileocecal urinary reservoir: mechanisms of urinary continence. J Urol. 1989 Oct; 142(4):1032-6. PMID: 2795726.
      View in: PubMed
    607. McAninch JW, Carroll P. Renal exploration after trauma. Indications and reconstructive techniques. Urol Clin North Am. 1989 May; 16(2):203-12. PMID: 2652850.
      View in: PubMed
    608. Mee SL, McAninch JW, Robinson AL, Auerbach PS, Carroll P. Radiographic assessment of renal trauma: a 10-year prospective study of patient selection. J Urol. 1989 May; 141(5):1095-8. PMID: 2709493.
      View in: PubMed
    609. Carroll P, McAninch JW. Staging of renal trauma. Urol Clin North Am. 1989 May; 16(2):193-201. PMID: 2652849.
      View in: PubMed
    610. Baskin L, Mee S, Matthay M, Carroll P. Ureteral obstruction caused by vasculitis. J Urol. 1989 Apr; 141(4):933-5. PMID: 2564444.
      View in: PubMed
    611. Carroll P, Klosterman P, McAninch JW. Early vascular control for renal trauma: a critical review. J Urol. 1989 Apr; 141(4):826-9. PMID: 2926873.
      View in: PubMed
    612. Presti JC, Carroll P, McAninch JW. Ureteral and renal pelvic injuries from external trauma: diagnosis and management. J Trauma. 1989 Mar; 29(3):370-4. PMID: 2926851.
      View in: PubMed
    613. Lue TF, Carroll P, Moore C. Treatment of impotence in cancer patients. Important Adv Oncol. 1989; 193-203. PMID: 2651288.
      View in: PubMed
    614. Carroll P, Narayan P. Treatment options for hormone-insensitive or independent prostatic carcinoma. Semin Urol. 1988 Nov; 6(4):322-35. PMID: 3068770.
      View in: PubMed
    615. Carroll P, Klosterman PW, McAninch JW. Surgical management of renal trauma: analysis of risk factors, technique, and outcome. J Trauma. 1988 Jul; 28(7):1071-7. PMID: 3398086.
      View in: PubMed
    616. Thurnher S, Hricak H, Carroll P, Pobiel RS, Filly RA. Imaging the testis: comparison between MR imaging and US. Radiology. 1988 Jun; 167(3):631-6. PMID: 3283834.
      View in: PubMed
    617. Bernstein SA, Reuter VE, Carroll P, Whitmore WF. Primary signet-ring cell carcinoma of urinary bladder. Urology. 1988 May; 31(5):432-6. PMID: 2834858.
      View in: PubMed
    618. Rebeck GW, Coons S, Carroll P, Samson L. A second DNA methyltransferase repair enzyme in Escherichia coli. Proc Natl Acad Sci U S A. 1988 May; 85(9):3039-43. PMID: 3283737; PMCID: PMC280138.
    619. Hricak H, Thoeni RF, Carroll P, Demas BE, Marotti M, Tanagho EA. Detection and staging of renal neoplasms: a reassessment of MR imaging. Radiology. 1988 Mar; 166(3):643-9. PMID: 3340757.
      View in: PubMed
    620. Carroll P, Morse MJ, Koduru PP, Chaganti RS. Testicular germ cell tumor in patient with Klinefelter syndrome. Urology. 1988 Jan; 31(1):72-4. PMID: 3336933.
      View in: PubMed
    621. Carroll P, Whitmore WF, Richardson M, Bajorunas D, Herr HW, Williams RD, Fair WR, Chaganti RS. Testicular failure in patients with extragonadal germ cell tumors. Cancer. 1987 Jul 1; 60(1):108-13. PMID: 3034394.
      View in: PubMed
    622. Carroll P, Morse MJ, Whitmore WF, Sogani PC, Klotz L, Herr HW, Fair WR, Feldshuh R, Chaganti RS. Fertility status of patients with clinical stage I testis tumors on a surveillance protocol. J Urol. 1987 Jul; 138(1):70-2. PMID: 3599224.
      View in: PubMed
    623. Carroll P, Murty VV, Reuter V, Jhanwar S, Fair WR, Whitmore WF, Chaganti RS. Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. Cancer Genet Cytogenet. 1987 Jun; 26(2):253-9. PMID: 3471307.
      View in: PubMed
    624. Carroll P, Whitmore WF, Herr HW, Morse MJ, Sogani PC, Bajorunas D, Fair WR, Chaganti RS. Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. J Urol. 1987 Mar; 137(3):420-3. PMID: 3029434.
      View in: PubMed
    625. Carroll P, Cattolica EV, Turzan CW, McAninch JW. Necrotizing soft-tissue infections of the perineum and genitalia. Etiology and early reconstruction. West J Med. 1986 Feb; 144(2):174-8. PMID: 3953086; PMCID: PMC1306554.
    626. Bretan PN, Carroll P, McClure RD, Williams RD. Improved continuous flow transurethral prostatectomy. J Urol. 1985 Jul; 134(1):77-80. PMID: 4009829.
      View in: PubMed
    627. Carroll P, McAninch JW. Operative indications in penetrating renal trauma. J Trauma. 1985 Jul; 25(7):587-93. PMID: 4009764.
      View in: PubMed
    628. Carroll P, Leitner TC, Yen TS, Watson RA, Williams RD. Incidental carcinoma of the prostate: significance of staging transurethral resection. J Urol. 1985 May; 133(5):811-4. PMID: 3989921.
      View in: PubMed
    629. Nicolaisen GS, McAninch JW, Marshall GA, Bluth RF, Carroll P. Renal trauma: re-evaluation of the indications for radiographic assessment. J Urol. 1985 Feb; 133(2):183-7. PMID: 3968728.
      View in: PubMed
    630. Carroll P, Lue TF, Schmidt RA, Trengrove-Jones G, McAninch JW. Penile replantation: current concepts. J Urol. 1985 Feb; 133(2):281-5. PMID: 3968751.
      View in: PubMed
    631. Carroll P, Williams RD, Kim MJ, Dombrovskis S. Mitomycin C reused: an in vitro cost-effectiveness study. J Urol. 1984 Sep; 132(3):583-6. PMID: 6433045.
      View in: PubMed
    632. Carroll P, McAninch JW. Major bladder trauma: mechanisms of injury and a unified method of diagnosis and repair. J Urol. 1984 Aug; 132(2):254-7. PMID: 6737572.
      View in: PubMed
    633. Carroll P, McAninch JW. Major bladder trauma: the accuracy of cystography. J Urol. 1983 Nov; 130(5):887-8. PMID: 6632094.
      View in: PubMed
    634. Carroll P, Pellegrini C, Hedgcock MW, Stein R, Williams RD. Microscopic hematuria, left renal mass with renal vein obstruction and elevated serum level of carcinoembryonic antigen in a 56-year-old man. J Urol. 1983 Mar; 129(3):568-73. PMID: 6300473.
      View in: PubMed
    635. McAninch JW, Carroll P. Renal trauma: kidney preservation through improved vascular control-a refined approach. J Trauma. 1982 Apr; 22(4):285-90. PMID: 7077686.
      View in: PubMed
    636. Willis AJ, Huang AH, Carroll P. Primary melanoma of the bladder: a case report and review. J Urol. 1980 Feb; 123(2):278-81. PMID: 7354540.
      View in: PubMed
    637. BAKER R, CARROLL P, HAYES D. SIGMOID SEGMENT FOR BLADDER SUBSTITUTE AFTER TOTAL OR SUBTOTAL CYSTECTOMY. J Urol. 1963 Sep; 90:289-95. PMID: 14055990.
      View in: PubMed
    Peter's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP